DENND5A-Related Developmental and Epileptic Encephalopathy

Mendelian MONDO:0015002 Pathograph 19 Show in embeddings browser Epilepsy Neurological Disease

DENND5A-related developmental and epileptic encephalopathy (DEE49) is an autosomal recessive disorder caused by biallelic loss-of-function variants in DENND5A, a DENN-domain protein that is both a candidate Rab guanine nucleotide exchange factor and a binding partner of the Crumbs apical polarity proteins MUPP1 and PALS1. The mechanism is developmental rather than primarily electrical: without DENND5A, apical neural progenitors misorient their mitotic spindles away from the ventricular surface, divide asymmetrically instead of symmetrically, and prematurely exit the cell cycle to differentiate into neurons. The progenitor pool is depleted before neurogenesis is complete, producing primary microcephaly, ventriculomegaly, cortical malformation and corpus callosum dysgenesis; the mispositioned, prematurely born neurons form aberrant connections and seizures follow. Cerebral calcifications and coarse facial features were part of the original clinical description.

Ask OpenScientist

Ask a research question about DENND5A-Related Developmental and Epileptic Encephalopathy. OpenScientist will conduct autonomous deep research using the Disorder Mechanisms Knowledge Base and PubMed literature (typically 10-30 minutes).

Submitting...

Do not include personal health information in your question. Questions and results are cached in your browser's local storage.

1
Inheritance
14
Pathophys.
18
Phenotypes
2
Hypotheses
5
Gaps
19
Pathograph
1
Genes
2
Medical Actions
4
Differentials
4
Models
1
Deep Research
👪

Inheritance

1
Autosomal recessive HP:0000007
Biallelic - homozygous in consanguineous families or compound heterozygous. In the 24-person cohort, 14 individuals were homozygous and 10 compound heterozygous. No point mutation was found homozygous in gnomAD, which is the population-genetic argument that two damaged alleles are not tolerated.
Autosomal recessive inheritance
Show evidence (2 references)
PMID:27866705 SUPPORT Human Clinical
"we have identified an epileptic encephalopathy additionally featuring cerebral calcifications and coarse facial features caused by recessive loss-of-function mutations in DENND5A"
The founding gene-disease report, establishing recessive loss of function.
PMID:39174524 SUPPORT Human Clinical
"None of the DENND5A point mutations in the cohort were found in the homozygous state among 140,000 individuals on gnomAD, a database that removes individuals affected by severe pediatric disease, indicating that biallelic pathogenic variants are likely incompatible with normal development"
Population-genetic support for the recessive model and for the severity of the biallelic state.

Mechanistic Hypotheses

2
apical_polarity_spindle_orientation_model
apical_polarity_spindle_orientation_model CANONICAL
Evidence balance 1 support
Loss of DENND5A removes a conformationally gated link to the MUPP1/PALS1 apical polarity complex, apical progenitors misorient their mitotic spindles, symmetric proliferative division is lost, the progenitor pool is depleted early, and neurogenesis is cut short - producing microcephaly and cortical malformation, with seizures arising from the mispositioned neurons. This is the account with quantitative support in human iPSC-derived cells and corroboration in mouse and zebrafish.
Show evidence (1 reference)
PMID:39174524 SUPPORT Human Clinical
"This study provides a mechanism for DENND5A-related DEE that may be generalizable to other developmental conditions and provides variant-specific clinical information for physicians and families"
The authors' framing of this as the mechanism for the disorder.
rab_trafficking_neurotrophin_model
rab_trafficking_neurotrophin_model ALTERNATIVE
Evidence balance 1 support
Loss of DENND5A's Rab-directed trafficking function raises neurotrophin receptor abundance and hence downstream signaling, and it is that signaling change that alters neuronal development. This was the founding account and it remains the one predicted by the protein's domain architecture, but it rests on knockdown experiments and has not been re-examined in the patient-derived neural progenitor and rosette systems that established the polarity mechanism. The two accounts are not mutually exclusive - a single protein with two conformations may serve both - and the trafficking arm is retained here rather than retired.
Show evidence (1 reference)
PMID:27866705 SUPPORT In Vitro
"Mechanistically, these changes appear to result from upregulation of neurotrophin receptors, leading to enhanced downstream signaling"
The founding mechanistic proposal, in the source's own hedged wording.
?

Discussions and Knowledge Gaps

5
If the disorder is caused by loss of DENND5A function, how does a recurrent variant that INCREASES binding to the polarity complex cause it?
CONTROVERSY OPEN controversy_r710h_gain_of_interaction_versus_loss_of_function
The two findings sit in direct tension and the entry does not smooth them. Every patient-derived cell line shows reduced DENND5A protein, and the population genetics support a recessive loss-of-function model. Yet R710H, a recurrent cohort variant, lies in the DENN-RUN1 linker where it is predicted to break a salt bridge holding the closed conformation, and introducing it experimentally increases binding to MUPP1 and PALS1. A protein locked open would engage the polarity complex more, not less. Three readings are available and none is excluded. The variant may be destabilizing in cells, so that reduced abundance overrides increased per-molecule affinity - the R710H individual in the cohort is compound heterozygous, which would matter here. Or the closed conformation may be functionally required - if DENND5A must cycle between a Rab-binding RUN1-exposed state and a polarity-binding open state, then constitutive opening is a loss of function even though it looks like a gain of binding. Or the polarity interaction may not be the arm through which R710H acts at all. Which reading is right determines whether R710H should be curated as a distinct mechanistic class within DEE49.
Proposed experiments
R710H knock-in iPSC rosettes with matched abundance measurement
exp_r710h_abundance_and_spindle_angle
Introduce R710H as a knock-in into wild-type human iPSCs and measure both DENND5A protein abundance and mitotic spindle angle in the resulting rosettes, against wild-type and full knockout. If R710H reduces abundance and misorients spindles, it is a loss-of-function allele whose binding gain is irrelevant in cells. If abundance is preserved and spindles are still misoriented, the closed conformation is functionally required and constitutive opening is itself the lesion.
By what molecular route does losing the DENND5A-MUPP1/PALS1 interaction change the orientation of the mitotic spindle?
KNOWLEDGE GAP OPEN gap_route_from_polarity_complex_to_spindle_angle
This is the entry's central unexplained step, and the obvious explanation has been tested and excluded. If DENND5A were required to deliver the polarity proteins to the apical membrane, their mislocalization would explain the spindle defect - but PALS1 localizes apically in knockout rosettes just as it does in wild-type, and the authors state directly that DENND5A is not involved in that trafficking. Something else therefore connects the interaction to spindle positioning: an effect on the astral microtubule capture machinery, on centrosome anchoring, on the local apical actin cortex, or an entirely separate DENND5A function. Without this step the disease model holds together descriptively but not mechanistically, and the edge is curated INDIRECT_UNKNOWN_INTERMEDIATES for exactly that reason.
Proposed experiments
Astral microtubule and cortical anchoring machinery in DENND5A knockout rosettes
exp_spindle_anchoring_machinery_in_dennd5a_ko
Image the LGN-NuMA-dynein cortical anchoring complex and astral microtubule contacts at the apical cortex of dividing wild-type and DENND5A knockout rosette progenitors, and test whether DENND5A or MUPP1/PALS1 co-localizes with or is required for that complex. A defect in cortical anchoring would supply the missing step; its absence would redirect the search toward centrosome positioning.
What actually makes DENND5A-deficient brain seize?
KNOWLEDGE GAP OPEN gap_evidence_for_the_seizure_step
The disorder is classified as a developmental and epileptic encephalopathy, and the developmental half is well evidenced down to quantitative spindle angles. The epileptic half is not. The proposed route - prematurely born neurons sitting in the wrong place and forming aberrant synaptic contacts - appears in the authors' disease model and is curated PARTIAL here because no measurement supports it: no source available to this entry reports excitation-inhibition balance, network synchrony, intrinsic excitability or synaptic physiology in DENND5A-deficient neurons. The mouse contributes threshold data only, and no spontaneous seizures. This is why this entry conforms to the epilepsy module at the clinical Recurrent Unprovoked Seizures endpoint rather than at the excitation-inhibition or hyperexcitability nodes: attaching upstream would let the module supply a mechanistic claim the evidence does not make. The authors themselves note that identifying whether excitatory or inhibitory neurons are disproportionately affected would help clinicians choose an antiseizure medication, which makes this gap clinically live rather than merely descriptive.
Proposed experiments
Excitatory and inhibitory neuron census and network physiology in DENND5A knockout
exp_excitatory_inhibitory_balance_in_dennd5a_deficient_cortex
Quantify excitatory and inhibitory neuron subpopulations across cortical layers in DENND5A knock-in mouse cortex at several developmental timepoints, and record network activity from DENND5A knockout human iPSC-derived neuronal cultures on multielectrode arrays. This tests whether the premature differentiation is subtype-biased and whether the resulting network is intrinsically hyperexcitable, which would convert the entry's inferential seizure step into a measured one.
Is the defect primarily in neuroepithelial cells or in apical radial glia?
KNOWLEDGE GAP OPEN gap_which_progenitor_stage_is_primarily_affected
The two progenitor stages differ in junctional composition - neuroepithelial cells have tight junctions, radial glia rely on adherens junctions - and MUPP1 is reported to preferentially stabilize adherens junctions over tight junctions. The authors take that asymmetry to predict a radial-glia-specific defect, but the prediction has not been tested: the rosette assay does not resolve the two stages, and the mouse data come from the adult subventricular zone rather than the embryonic ventricular zone. Which stage is affected sets the developmental window and hence what a hypothetical intervention would have to reach.
Proposed experiments
Stage-resolved spindle angle measurement in the embryonic mouse ventricular zone
exp_stage_resolved_spindle_angles_in_vivo
Measure mitotic spindle angles of dividing apical progenitors in the DENND5A knock-in mouse ventricular zone across the neuroepithelial-to-radial-glia transition, with stage markers, and quantify progenitor and post-mitotic proportions at each timepoint. This is the experiment the authors themselves propose, and it would establish both the affected stage and whether the in vivo spindle defect matches the rosette measurement.
Does increased neuronal differentiation in the adult mouse subventricular zone speak to a defect in human embryonic cortical neurogenesis?
HUMAN MODEL MISMATCH OPEN mismatch_adult_svz_as_proxy_for_embryonic_neurogenesis
The in vivo evidence for premature differentiation comes from the adult subventricular zone, while the disease model is about embryonic cortical neurogenesis. These are different niches with different progenitors, different output lineages and different regulatory logic; adult SVZ neurogenesis produces olfactory bulb interneurons in mouse and is of contested extent in adult humans at all. The authors chose the niche because it retains GFAP-positive radial-glia-like stem cells, which is a reasonable analogy, but an analogy is what it is. Compounding this, the mouse fails to reproduce the microcephaly that the embryonic defect is supposed to cause - relative brain size was lower but not significantly so. The human iPSC rosette and progenitor data carry the developmental claim; the mouse SVZ result corroborates it in an adjacent system and should not be read as confirming it in the relevant one.
Proposed experiments
Embryonic ventricular zone progenitor and neuron census across neurogenesis
exp_embryonic_vz_differentiation_timecourse
Quantify progenitor and post-mitotic neuron proportions in the DENND5A knock-in mouse embryonic ventricular and subventricular zones across the full neurogenic period, and compare the trajectory to wild-type. If the premature-differentiation shift is present embryonically and cortically, the adult SVZ result becomes corroboration rather than the primary in vivo evidence; if it is absent, the mouse does not model the human developmental mechanism and the microcephaly failure is explained.

Pathophysiology

14
Biallelic DENND5A Loss-of-Function Variants
The initiating lesion. Thirty unique variants have been reported across 22 families, spread over the whole protein rather than clustering in one domain: nine in the DENN domain, two in RUN1, six in PLAT, four in RUN2 and four in the linkers, plus copy number and splice-site variants. That distribution is itself mechanistically informative - it is what a loss-of-function disorder looks like, as opposed to the domain-restricted clustering seen in gain-of-function DEEs.
DENND5A hgnc:19344 HUGO Gene Nomenclature Committee (hgnc) Relation: this pathophysiological event involves this gene This pathophysiological event involves DENND5A (hgnc:19344). hgnc:19344 is a gene from the HUGO Gene Nomenclature Committee.
Show evidence (2 references)
PMID:39174524 SUPPORT Human Clinical
"Thirty unique DENND5A variants were identified across the 14 homozygous and 10 compound heterozygous individuals"
Establishes the size and allelic architecture of the reported variant spectrum.
PMID:39174524 SUPPORT Human Clinical
"The coding variants span the length of the protein including nine in the DENN domain, two in the RUN1 domain, six in the PLAT domain, four in the RUN2 domain, and four in predicted linker regions between the folded modules"
Documents that variants are distributed across the protein rather than clustered, consistent with loss of function.
Reduced DENND5A Protein
The convergent proximal consequence. Cells from five cohort members - three iPSC-derived neural progenitor lines and two immortalized lymphoblast lines, spanning frameshift, nonsense and missense variants - all show reduced DENND5A protein. The reduction is post-transcriptional: patient mRNA levels do not differ significantly from controls, so the protein is lost after it is made rather than because the transcript is absent. This node is curated separately from the variants above because the protein and transcript measurements come apart, and it is the protein measurement that carries the loss-of-function claim.
neural progenitor cell CL:0011020 Cell Ontology (CL) Relation: this pathophysiological event involves this cell type This pathophysiological event involves neural progenitor cell (CL:0011020). CL:0011020 is a cell type from the Cell Ontology.
Show evidence (2 references)
PMID:39174524 SUPPORT In Vitro
"All patient-derived cells exhibit a reduction in DENND5A protein (Supplementary Fig. 2a, b), supporting that disease phenotypes are a result of protein loss of function"
The direct measurement establishing protein loss of function across variant classes.
PMID:39174524 SUPPORT In Vitro
"A rather poor correlation between DENND5A mRNA and protein levels was observed as DENND5A mRNA expression from patient-derived cells did not differ significantly from controls"
Locates the defect after transcription, which is why the protein and transcript claims are curated as separate measurements.
Loss of DENND5A-MUPP1/PALS1 Association at the Apical Membrane
DENND5A binds MUPP1 and PALS1, two components of the Crumbs apical polarity complex that is required for symmetric division of neural progenitors. The interaction is conformation-dependent: full-length DENND5A binds these partners only weakly, because the binding region makes intramolecular contacts with the DENN domain, and a conformational change is needed to expose it. Losing DENND5A therefore removes a conformationally gated link into the apical polarity machinery, which is the point at which this trafficking protein becomes a developmental one.
Crumbs apical polarity complex (MUPP1-PALS1) Relation: this pathophysiological event involves this protein complex This pathophysiological event involves Crumbs apical polarity complex (MUPP1-PALS1).
establishment or maintenance of cell polarity GO:0007163 Gene Ontology (GO) Relation: this pathophysiological event involves this biological process This pathophysiological event involves decreased establishment or maintenance of cell polarity (GO:0007163). GO:0007163 is a biological process from the Gene Ontology. ↓ DECREASED
apical plasma membrane GO:0016324 Gene Ontology (GO) Relation: this pathophysiological event involves this cellular component This pathophysiological event involves apical plasma membrane (GO:0016324). GO:0016324 is a cellular component from the Gene Ontology.
Show evidence (3 references)
PMID:39174524 SUPPORT In Vitro
"Mass spectrometry of purified proteins revealed members of the Crb polarity complex, MUPP1, and PALS1, as major DENND5A binding partners"
Identifies the polarity-complex partners by unbiased proteomics.
PMID:39174524 SUPPORT In Vitro
"This suggests a conformational change in DENND5A is necessary to expose the binding site for MUPP1/PALS1. In fact, full-length DENND5A has limited interaction with these proteins"
Establishes that the interaction is gated by DENND5A's conformation, which is what the R710H variant later exploits.
PMID:39174524 SUPPORT In Vitro
"We demonstrate that DENND5A interacts with Pals1/MUPP1, components of the Crumbs apical polarity complex required for symmetrical division of neural progenitor cells"
Links the interaction to the specific cellular process the disorder disrupts.
Impaired Rab-Directed Membrane Trafficking
The second, older mechanistic thread, and the one the gene is named for. DENND5A carries a DENN domain, the module that confers guanine nucleotide exchange factor activity toward Rab GTPases, and two RUN domains through which it binds active Rab6 and sorting nexin 1. Structural modeling qualifies this: the predicted Rab enzymatic site may be occluded by the DENN-RUN1/PLAT interaction in the closed conformation, while Rab6 binding to RUN1 needs no conformational change - so the two functions are predicted to require different conformations of the same protein. This node is kept separate from the polarity arm rather than merged into it, because no source available to this entry shows that trafficking loss is what causes the spindle defect.
vesicle-mediated transport GO:0016192 Gene Ontology (GO) Relation: this pathophysiological event involves this biological process This pathophysiological event involves decreased vesicle-mediated transport (GO:0016192). GO:0016192 is a biological process from the Gene Ontology. ↓ DECREASED retrograde transport, endosome to Golgi GO:0042147 Gene Ontology (GO) Relation: this pathophysiological event involves this biological process This pathophysiological event involves retrograde transport, endosome to Golgi (GO:0042147). GO:0042147 is a biological process from the Gene Ontology.
guanyl-nucleotide exchange factor activity GO:0005085 Gene Ontology (GO) Relation: this pathophysiological event involves this molecular function This pathophysiological event involves decreased guanyl-nucleotide exchange factor activity (GO:0005085). GO:0005085 is a molecular function from the Gene Ontology. ↓ DECREASED
Show evidence (2 references)
PMID:27866705 SUPPORT In Vitro
"DENND5A contains a DENN domain, an evolutionarily ancient enzymatic module conferring guanine nucleotide exchange factor (GEF) activity to multiple proteins serving as GEFs for Rabs, which are key regulators of membrane trafficking"
Establishes the DENN domain's expected enzymatic role in membrane trafficking.
PMID:39174524 SUPPORT Computational
"we aligned the co-crystal structure of DENND1B and Rab35 with the predicted DENND5A structure and found that the predicted Rab enzymatic site in DENND5A may be occluded by interactions between the DENN and RUN1 (RPIP8, UNC-14 and NESCA)/PLAT (Polycystin-1, Lipoxygenase, Alpha-Toxin) domains"
Curated PARTIAL: a structural prediction that qualifies the GEF assignment rather than a measurement of exchange activity. No source available to this entry reports DENND5A GEF activity assayed directly against a Rab substrate.
Neurotrophin Receptor Upregulation and Enhanced Downstream Signaling
In the founding study, knocking DENND5A down altered neuronal development, and the change appeared to be mediated by an increase in neurotrophin receptors and hence in downstream signaling. This is a knockdown-derived account from 2016 and has not been reproduced in the patient-derived systems used in the 2024 cohort study, so it is curated as a parallel arm reaching the same developmental endpoint rather than as a step in the spindle chain.
neurotrophin TRK receptor signaling pathway GO:0048011 Gene Ontology (GO) Relation: this pathophysiological event involves this biological process This pathophysiological event involves increased neurotrophin TRK receptor signaling pathway (GO:0048011). GO:0048011 is a biological process from the Gene Ontology. ↑ INCREASED
Show evidence (1 reference)
PMID:27866705 SUPPORT In Vitro
"Knockdown of DENND5A leads to striking alterations in neuronal development. Mechanistically, these changes appear to result from upregulation of neurotrophin receptors, leading to enhanced downstream signaling"
The knockdown result and the receptor-upregulation account offered for it. The source's own hedge - "appear to result from" - is preserved in the description.
Mitotic Spindle Misorientation in Apical Neural Progenitors
The rate-limiting cellular defect. In human iPSC-derived neural rosettes - a polarized in vitro model of early neural development - the angle between the cleavage plane and the apical surface collapses when DENND5A is absent. Wild-type progenitors divide with a mean spindle angle of 57.1 degrees, close to the plane that gives both daughters equal access to the apical surface; knockout progenitors divide at 26.0 degrees, and an overwhelming majority fall below 45 degrees.
apical radial glial cell CL:0000681 Cell Ontology (CL) Relation: this pathophysiological event involves this cell type This pathophysiological event involves apical radial glial cell, annotated with radial glial cell (CL:0000681). CL:0000681 is a cell type from the Cell Ontology.
establishment of mitotic spindle orientation GO:0000132 Gene Ontology (GO) Relation: this pathophysiological event involves this biological process This pathophysiological event involves decreased establishment of mitotic spindle orientation (GO:0000132). GO:0000132 is a biological process from the Gene Ontology. ↓ DECREASED
mitotic spindle GO:0072686 Gene Ontology (GO) Relation: this pathophysiological event involves this cellular component This pathophysiological event involves mitotic spindle (GO:0072686). GO:0072686 is a cellular component from the Gene Ontology.
Show evidence (2 references)
PMID:39174524 SUPPORT In Vitro
"the spindle angle among cells dividing within WT (M = 57.1°, Mdn = 65.4°, SD = 25.9) and KO (M = 26.0°, Mdn = 20.1°, SD = 19.0) rosettes differed significantly"
The quantitative spindle-angle measurement in human iPSC-derived neural rosettes.
PMID:39174524 SUPPORT In Vitro
"These phenotypes result from misalignment of the mitotic spindle in apical neural progenitors"
The authors' own placement of spindle misalignment as the causal step.
Loss of Symmetric Proliferative Division
An oblique cleavage plane means only one daughter keeps contact with the apical ventricular surface and inherits the apical determinants MUPP1 and PALS1. The other is displaced basally and receives less of the stem-cell-niche signal, so it is biased toward commitment. The division that should have produced two progenitors produces one progenitor and one committed cell.
apical radial glial cell CL:0000681 Cell Ontology (CL) Relation: this pathophysiological event involves this cell type This pathophysiological event involves apical radial glial cell, annotated with radial glial cell (CL:0000681). CL:0000681 is a cell type from the Cell Ontology.
symmetric cell division GO:0098725 Gene Ontology (GO) Relation: this pathophysiological event involves this biological process This pathophysiological event involves decreased symmetric cell division (GO:0098725). GO:0098725 is a biological process from the Gene Ontology. ↓ DECREASED asymmetric cell division GO:0008356 Gene Ontology (GO) Relation: this pathophysiological event involves this biological process This pathophysiological event involves increased asymmetric cell division (GO:0008356). GO:0008356 is a biological process from the Gene Ontology. ↑ INCREASED
Show evidence (2 references)
PMID:39174524 SUPPORT In Vitro
"indicating that DENND5A KO results in increased levels of oblique asymmetric cell divisions and the ability for apical progenitors to self-renew is severely compromised"
States the division-mode shift and its consequence for self-renewal.
PMID:39174524 SUPPORT In Vitro
"Cells lacking DENND5A orient away from the proliferative apical domain surrounding the ventricles, biasing daughter cells towards a more fate-committed state"
Connects loss of apical contact to the fate bias in the daughter cells.
Premature Neuronal Differentiation and Cell Cycle Exit
Knockout progenitors do not merely divide differently, they are inherently more likely to leave the cycle. One day after passaging into progenitor maintenance medium - conditions meant to keep them undifferentiated - 47.29 percent of knockout cells had developed neuronal processes against 10.67 percent of wild-type. The same shift is present in the adult mouse: knock-in animals have a higher proportion of NeuN-positive post-mitotic neurons in the subventricular zone. This is a propensity of the cells themselves, which is why it is curated as its own node with an input from the division defect rather than only as its consequence.
neural progenitor cell CL:0011020 Cell Ontology (CL) Relation: this pathophysiological event involves this cell type This pathophysiological event involves neural progenitor cell (CL:0011020). CL:0011020 is a cell type from the Cell Ontology.
neuron differentiation GO:0030182 Gene Ontology (GO) Relation: this pathophysiological event involves this biological process This pathophysiological event involves increased neuron differentiation (GO:0030182). GO:0030182 is a biological process from the Gene Ontology. ↑ INCREASED cell fate commitment GO:0045165 Gene Ontology (GO) Relation: this pathophysiological event involves this biological process This pathophysiological event involves increased cell fate commitment (GO:0045165). GO:0045165 is a biological process from the Gene Ontology. ↑ INCREASED
Show evidence (3 references)
PMID:39174524 SUPPORT In Vitro
"Our results suggest that DENND5A expression promotes stemness and its loss drives cell cycle exit and premature differentiation into neuronal phenotypes"
The authors' summary of the differentiation phenotype across their in vitro and in vivo measurements.
PMID:39174524 SUPPORT In Vitro
"Human induced pluripotent stem cells lacking DENND5A fail to undergo symmetric cell division with an inherent propensity to differentiate into neurons"
States the propensity as inherent to the cells, not only a consequence of the division geometry.
PMID:39174524 SUPPORT Model Organism
"KI mice have a significantly higher percentage of post-mitotic neurons expressing NeuN compared to WT mice"
In vivo corroboration in the knock-in mouse subventricular zone.
Neural Progenitor Pool Depletion
The two upstream defects - fewer self-renewing divisions and more cells leaving the cycle - both subtract from the same pool, and the pool is measurably smaller. Equal numbers of wild-type and knockout progenitors plated together diverge within two days: 1008 wild-type cells per well against 614 knockout, and by 72 hours 1685 against 683. Wild-type numbers climb while knockout numbers stay nearly flat.
neural progenitor cell CL:0011020 Cell Ontology (CL) Relation: this pathophysiological event involves this cell type This pathophysiological event involves neural progenitor cell (CL:0011020). CL:0011020 is a cell type from the Cell Ontology.
neural precursor cell proliferation GO:0061351 Gene Ontology (GO) Relation: this pathophysiological event involves this biological process This pathophysiological event involves decreased neural precursor cell proliferation (GO:0061351). GO:0061351 is a biological process from the Gene Ontology. ↓ DECREASED
Show evidence (1 reference)
PMID:39174524 SUPPORT In Vitro
"WT NPCs then rapidly increased in number whereas the number of KO NPCs remained relatively stable"
The proliferation divergence between wild-type and knockout progenitors.
Shortened Period of Neurogenesis
The developmental endpoint of the progenitor arithmetic. Neurogenesis in the developing cortex is bounded by how long a progenitor pool of sufficient size persists; when the pool is depleted early, the window closes early and fewer neurons, of fewer lineages, are produced.
neurogenesis GO:0022008 Gene Ontology (GO) Relation: this pathophysiological event involves this biological process This pathophysiological event involves decreased neurogenesis (GO:0022008). GO:0022008 is a biological process from the Gene Ontology. ↓ DECREASED cerebral cortex development GO:0021987 Gene Ontology (GO) Relation: this pathophysiological event involves this biological process This pathophysiological event involves decreased cerebral cortex development (GO:0021987). GO:0021987 is a biological process from the Gene Ontology. ↓ DECREASED
Show evidence (2 references)
PMID:39174524 SUPPORT In Vitro
"biasing daughter cells towards a more fate-committed state, ultimately shortening the period of neurogenesis"
Names the shortened neurogenic period as the outcome of the fate bias.
PMID:39174524 SUPPORT Human Clinical
"Ultimately, this results in a shortened period of neurogenesis which leads to microcephaly and/or observable abnormalities in gray and white matter structures"
The authors' own statement of the link from shortened neurogenesis to the structural brain phenotype.
Reduced Brain Volume and Cortical Malformation
The structural phenotype: microcephaly, reduced white matter volume, pachygyria with an occipital predominance, basal ganglia and diencephalic-mesencephalic junction dysplasia, corpus callosum agenesis or hypoplasia, and striatal and periventricular calcifications. Corpus callosum volume in the cohort was normal, thin or absent, never increased - a detail that distinguishes this from the LIS1 tubulinopathy differential.
cerebral cortex UBERON:0000956 Uberon multi-species anatomy ontology (UBERON) Relation: this pathophysiological event occurs in this anatomical location This pathophysiological event occurs in cerebral cortex (UBERON:0000956). UBERON:0000956 is an anatomical location from the Uberon multi-species anatomy ontology.
Show evidence (2 references)
PMID:39174524 SUPPORT Human Clinical
"cortical malformations, particularly with pachygyria involving the occipital lobes, a reduced volume of the white matter with associated striatal and periventricular calcifications and ventriculomegaly, agenesis or severe dysplasia/hypoplasia of the corpus callosum"
The structural MRI phenotype as reported in the cohort.
PMID:39174524 SUPPORT Human Clinical
"These imaging studies highlight the heterogenous neuroanatomical manifestations of biallelic DENND5A variants, but certain features including volume loss, ventriculomegaly, and hypoplasia of the corpus callosum appear more frequently"
Records both the heterogeneity and the recurrent features.
Compensatory Ventriculomegaly
Ventricular enlargement is present in 15 of 24 individuals and is reproduced in the knock-in mouse by 7T MRI. The 2024 study reads it as compensatory - space vacated by the reduced neuronal volume - rather than as an independent obstructive or resorptive process. That reading is an interpretation offered by the source, not a measurement, and is recorded as such.
Show evidence (2 references)
PMID:39174524 SUPPORT Human Clinical
"The reduced volume of neurons likely leads to compensatory ventriculomegaly"
The compensatory interpretation, hedged by the source with "likely" and preserved here as such.
PMID:39174524 SUPPORT Model Organism
"In vivo 7T MRI scans revealed that DENND5A KI mice have significantly enlarged lateral ventricles (MWT = 4.8 mm3, MKI = 6.6 mm3, SDWT = 1.3, SDKI = 2.4, two-tailed Mann-Whitney U, Z = −2.117, p = 0.034), consistent with ventriculomegaly"
Quantitative in vivo reproduction of the ventriculomegaly in the mouse model.
Aberrant Positioning and Connectivity of Prematurely Born Neurons
Neurons born too early and displaced from the ventricular surface end up in the wrong laminar position and, where they escape apoptosis, form synaptic contacts they should not have. This is the proposed bridge from the developmental defect to the epilepsy, and it is the least directly evidenced step in the chain: it is asserted in the authors' disease model, not measured. The edge into seizure generation is marked accordingly.
neuron CL:0000540 Cell Ontology (CL) Relation: this pathophysiological event involves this cell type This pathophysiological event involves neuron (CL:0000540). CL:0000540 is a cell type from the Cell Ontology.
Show evidence (1 reference)
PMID:39174524 SUPPORT Human Clinical
"improperly positioned prematurely-born neurons that do not undergo apoptosis and form aberrant synaptic contacts results in seizures that can further adversely affect development"
Curated PARTIAL: this is the proposed disease model, stated in the discussion, not a measurement of synaptic connectivity in patient or model tissue.
Seizure Generation and Developmental and Epileptic Encephalopathy
Recurrent, usually drug-resistant seizures in 21 of 24 individuals, with focal to bilateral tonic-clonic the most common type. Seizures then act back on development, the defining feature of a developmental and epileptic encephalopathy. Conformance attaches at the module's Recurrent Unprovoked Seizures node - the clinical endpoint - and not at the upstream excitation-inhibition or hyperexcitability nodes, because no ion-channel or synaptic measurement exists for this disorder to support those. The developmental encephalopathy here has an independent origin in the neurogenesis defect and is not solely seizure-driven.
Show evidence (2 references)
PMID:39174524 SUPPORT Human Clinical
"The phenotypes observed in more than 50% of individuals with biallelic DENND5A variants were seizures (21/24), microcephaly (16/24), ventriculomegaly (15/24), hypertonia (14/24), cerebral hypoplasia (13/24), and hyperreflexia (13/24)"
Quantifies seizures as the most frequent feature of the cohort.
PMID:39174524 SUPPORT Human Clinical
"Developmental and epileptic encephalopathies (DEEs) feature altered brain development, developmental delay and seizures, with seizures exacerbating developmental delay"
States the DEE construct - seizures acting back on development - that this endpoint instantiates.

Pathograph

Use the checkboxes to hide or show graph categories. Hover nodes for evidence and cross-linked metadata.
Pathograph: causal mechanism network for DENND5A-Related Developmental and Epileptic Encephalopathy Interactive directed graph showing how pathophysiology mechanisms, phenotypes, genetic factors and variants, experimental models, environmental triggers, and treatments relate through causal and linked edges.

Phenotypes

18
Head and Neck 1
Coarse Facial Features HP:0000280 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Coarse facial features (HP:0000280). HP:0000280 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:27866705 SUPPORT Human Clinical
"an epileptic encephalopathy additionally featuring cerebral calcifications and coarse facial features"
Names coarse facial features in the founding description.
Musculoskeletal 1
Hypertonia FREQUENT HP:0001276 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Hypertonia (HP:0001276). HP:0001276 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:39174524 SUPPORT Human Clinical
"ventriculomegaly (15/24), hypertonia (14/24), cerebral hypoplasia (13/24), and hyperreflexia (13/24)"
14/24 is 58 percent, in the FREQUENT band (30-79 percent).
Nervous System 8
Global Developmental Delay VERY_FREQUENT HP:0001263 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Global developmental delay (HP:0001263). HP:0001263 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:39174524 SUPPORT Human Clinical
"Failure to meet key developmental milestones was almost universal in the cohort, evidenced by the fact that all but one (participant 8; p.K485E/p.R1159W) presented with or had a history of global developmental delay"
23/24 is 96 percent, in the VERY_FREQUENT band (80-99 percent). The source names both the count and the single exception, so the band is derived rather than estimated.
Intellectual Disability VERY_FREQUENT HP:0001249 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Intellectual disability (HP:0001249). HP:0001249 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:39174524 SUPPORT Human Clinical
"Among cohort members assessed after age 5, 9 had severe intellectual disability (ID), profound ID was reported for 3 individuals, moderate ID was observed in 2 cases, and one participant (8) had no ID"
14 of the 15 assessed individuals had intellectual disability, which is 93 percent and falls in the VERY_FREQUENT band. Note the denominator is the assessed subset, not the whole cohort - the band is over those old enough to be assessed.
Seizures VERY_FREQUENT HP:0001250 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Seizure (HP:0001250). HP:0001250 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:39174524 SUPPORT Human Clinical
"The phenotypes observed in more than 50% of individuals with biallelic DENND5A variants were seizures (21/24), microcephaly (16/24), ventriculomegaly (15/24), hypertonia (14/24), cerebral hypoplasia (13/24), and hyperreflexia (13/24)"
21/24 is 88 percent, which falls in the VERY_FREQUENT band (80-99 percent).
Epileptic Spasms OCCASIONAL HP:0011097 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Epileptic spasm (HP:0011097). HP:0011097 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:39174524 SUPPORT Human Clinical
"Among the 6 individuals presenting with epileptic spasms, 3 had a generalized onset, 2 had a focal onset, and 1 had an unknown onset"
6/24 is 25 percent, in the OCCASIONAL band (5-29 percent).
Ventriculomegaly FREQUENT HP:0002119 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Ventriculomegaly (HP:0002119). HP:0002119 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:39174524 SUPPORT Human Clinical
"microcephaly (16/24), ventriculomegaly (15/24), hypertonia (14/24), cerebral hypoplasia (13/24), and hyperreflexia (13/24)"
15/24 is 63 percent, in the FREQUENT band (30-79 percent).
Hyperreflexia FREQUENT HP:0001347 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Hyperreflexia (HP:0001347). HP:0001347 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:39174524 SUPPORT Human Clinical
"cerebral hypoplasia (13/24), and hyperreflexia (13/24)"
13/24 is 54 percent, in the FREQUENT band (30-79 percent).
Absent Speech FREQUENT HP:0001344 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Absent speech (HP:0001344). HP:0001344 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:39174524 SUPPORT Human Clinical
"Of the individuals, 15/24 (63%) were nonverbal, 7/24 (29%) were limited to single-word speech, and 2/24 (8%) could speak in sentences"
63 percent nonverbal falls in the FREQUENT band (30-79 percent); the figure is stated directly by the source.
Corpus Callosum Hypoplasia or Agenesis Hypoplasia of the corpus callosum HP:0002079 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Hypoplasia of the corpus callosum (HP:0002079). HP:0002079 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:39174524 SUPPORT Human Clinical
"In contrast, corpus callosum volumes were either normal, thin, or absent with no cases of increased volume in our cohort"
Records the callosal finding and its direction, which is what distinguishes it from the LIS1 pattern.
Other 8
Inability to Walk Independently FREQUENT HP:0002540 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Inability to walk (HP:0002540). HP:0002540 is a phenotype from the Human Phenotype Ontology.
Show evidence (2 references)
PMID:39174524 SUPPORT Human Clinical
"Eight of twenty-four individuals (33%) could walk independently and 11/24 (46%) were able to reach for and grasp objects"
The complement, 16/24 or 67 percent, falls in the FREQUENT band. The band is derived from the stated count rather than quoted directly, which is why the derivation is spelled out here.
PMID:39174524 SUPPORT Human Clinical
"Motor capabilities were more severely affected in those with microcephaly (MMicro = 3.2, MNo micro = 7.2, SDMicro = 3.5, SDNo micro = 3.4, two-tailed Mann-Whitney U, Z = −2.55, p = 0.011"
Quantifies the association between microcephaly and motor outcome, which is the one within-cohort predictor of motor severity the study reports besides variant class.
Focal to Bilateral Tonic-Clonic Seizures FREQUENT Bilateral tonic-clonic seizure with focal onset HP:0007334 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Bilateral tonic-clonic seizure with focal onset (HP:0007334). HP:0007334 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:39174524 SUPPORT Human Clinical
"Focal to bilateral tonic-clonic is the most prominent seizure type, diagnosed in 9 individuals"
9/24 is 38 percent, in the FREQUENT band (30-79 percent).
Drug-Resistant Epilepsy Refractory drug response HP:0020174 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Refractory drug response (HP:0020174). HP:0020174 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:39174524 SUPPORT Human Clinical
"Seizures were generally drug-resistant, but control was achieved in 6 cases with variable antiepileptic treatment"
States drug resistance as the general pattern with a minority achieving control.
Primary Microcephaly FREQUENT HP:0011451 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Primary microcephaly (HP:0011451). HP:0011451 is a phenotype from the Human Phenotype Ontology.
Show evidence (2 references)
PMID:39174524 SUPPORT Human Clinical
"All cases of microcephaly in the cohort were primary, with no cases of secondary microcephaly reported"
Establishes the microcephaly as primary, which is what ties it to the prenatal neurogenesis defect rather than to postnatal degeneration.
PMID:39174524 SUPPORT Human Clinical
"seizures (21/24), microcephaly (16/24), ventriculomegaly (15/24), hypertonia (14/24), cerebral hypoplasia (13/24), and hyperreflexia (13/24)"
16/24 is 67 percent, in the FREQUENT band (30-79 percent).
Cerebral Hypoplasia FREQUENT HP:0006872 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Cerebral hypoplasia (HP:0006872). HP:0006872 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:39174524 SUPPORT Human Clinical
"hypertonia (14/24), cerebral hypoplasia (13/24), and hyperreflexia (13/24)"
13/24 is 54 percent, in the FREQUENT band (30-79 percent).
Reduced Eye Contact FREQUENT HP:0000817 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Reduced eye contact (HP:0000817). HP:0000817 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:39174524 SUPPORT Human Clinical
"Eye contact was observed in 11 of 24 individuals (46%)"
The complement, 13/24 or 54 percent, falls in the FREQUENT band. The band is derived from the stated count rather than quoted directly, which is why the derivation is spelled out here.
Cerebral Calcification HP:0002514 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Cerebral calcification (HP:0002514). HP:0002514 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:27866705 SUPPORT Human Clinical
"we have identified an epileptic encephalopathy additionally featuring cerebral calcifications and coarse facial features"
Names calcifications as part of the founding clinical description. No cohort-wide frequency is reported for calcifications, so no frequency band is asserted.
Pachygyria HP:0001302 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Pachygyria (HP:0001302). HP:0001302 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:39174524 SUPPORT Human Clinical
"cortical malformations, particularly with pachygyria involving the occipital lobes"
Locates the cortical malformation and its posterior gradient.
🧬

Genetic Associations

1
DENND5A (Biallelic loss-of-function variants in DENND5A cause DEE49. Thirty unique variants are reported across 22 families - 25 coding, 2 copy number and 3 splice-site - distributed across all folded domains. Variant class is itself a severity modifier: biallelic frameshift or nonsense variants produce significantly more neurological abnormality than biallelic missense variants.)
Gene: DENND5A hgnc:19344 HUGO Gene Nomenclature Committee (hgnc) Relation: this disease-associated gene is this gene This disease-associated gene is DENND5A (hgnc:19344). hgnc:19344 is a gene from the HUGO Gene Nomenclature Committee. relationship_type: CAUSATIVE
Show evidence (3 references)
PMID:27866705 SUPPORT Human Clinical
"caused by recessive loss-of-function mutations in DENND5A"
The gene-disease assertion.
PMID:39174524 SUPPORT Human Clinical
"found that variant type influences neurological phenotype severity, with more abnormalities in individuals with biallelic frameshift or nonsense variants (M = 7.6, SD = 2.3) compared to those with biallelic missense variants (M = 2.8, SD = 1.6, p = 0.0004)"
Quantifies variant class as a severity modifier, with the statistic.
PMID:39174524 SUPPORT Human Clinical
"Additionally, those with biallelic missense variants in DENND5A (M = 7.4, SD = 3.7) had significantly higher motor scores compared to those with a combination of missense, frameshift, nonsense, intronic, or copy number variants (M = 2.9, SD = 3.0, Kruskal-Wallis H = 7.02, p = 0.03"
The parallel gradient in motor outcome across the same variant classes.
💊

Medical Actions

2
Antiseizure Medication
Action: PharmacotherapyNCI Thesaurus (NCIT) Relation: this treatment is this clinical intervention This treatment is Pharmacotherapy (NCIT:C15986). NCIT:C15986 is a clinical intervention from the NCI Thesaurus. NCIT:C15986
Agent: levetiracetam CHEBI:6437 Chemical Entities of Biological Interest (CHEBI) Relation: this treatment uses this therapeutic agent This treatment uses levetiracetam (CHEBI:6437). CHEBI:6437 is a therapeutic agent from Chemical Entities of Biological Interest. valproic acid CHEBI:39867 Chemical Entities of Biological Interest (CHEBI) Relation: this treatment uses this therapeutic agent This treatment uses valproic acid (CHEBI:39867). CHEBI:39867 is a therapeutic agent from Chemical Entities of Biological Interest.
Management is symptomatic. No agent has disease-specific efficacy evidence, seizures are generally drug-resistant, and the cohort record includes agents that worsened seizures as well as agents that helped - phenytoin and lamotrigine each worsened seizures in one individual. Levetiracetam and sodium valproate were the most commonly reported agents achieving control.
Show evidence (1 reference)
PMID:39174524 SUPPORT Human Clinical
"Seizures were generally drug-resistant, but control was achieved in 6 cases with variable antiepileptic treatment. Anti-seizure medications variably helped, did not affect, or worsened seizures"
Curated PARTIAL: it records a mixed and often unsuccessful response, not an effective treatment. The explicit inclusion of worsening is why this cannot be read as support for antiseizure medication as such.
Genetic Counseling
Action: Genetic CounselingNCI Thesaurus (NCIT) Relation: this treatment is this clinical intervention This treatment is Genetic Counseling (NCIT:C15240). NCIT:C15240 is a clinical intervention from the NCI Thesaurus. NCIT:C15240
Autosomal recessive with a 25 percent recurrence risk per pregnancy for carrier couples. Consanguinity was a feature of the founding families, which is the standard context for identifying biallelic rare-variant disease.
Show evidence (2 references)
PMID:39174524 SUPPORT Human Clinical
"For families in which one parent is aware they are a carrier of a pathogenic DENND5A variant, genetic counselors can recommend the other parent undergo genetic testing. When both parents are carriers, in vitro fertilization with preimplantation genetic diagnosis can be offered"
Names genetic counselors, carrier testing of the second parent, and IVF with preimplantation genetic diagnosis - the reproductive options this treatment entry asserts. This replaces an earlier quote that was the paper's generic closing sentence about being clinically informative, which did not state any of it.
PMID:39174524 SUPPORT Human Clinical
"the presence of DENND5A VUSs does not necessarily equate to a devastating prognosis; 13% (3 cases) of our small cohort did not meet criteria for DEE or experience seizures at the time of data collection"
Curated PARTIAL because it qualifies rather than supports: the counseling message is not uniformly severe. This is the same 3 of 24 recorded on the seizure endpoint node, and it is the counseling-relevant reading of that number.
🔬

Diagnosis

2
Brain Magnetic Resonance Imaging
Neuroimaging is how these patients reach genetic testing rather than how the diagnosis is made. The imaging phenotype is distinctive enough to prompt a specific search - occipital-predominant pachygyria with striatal and periventricular calcifications, ventriculomegaly, corpus callosum agenesis or hypoplasia, basal ganglia and diencephalic-mesencephalic junction dysplasia - but not specific enough to settle it, since the same constellation raises OCLN-related disease, the tubulinopathies, LIS1-related lissencephaly and congenital infection.
Magnetic Resonance Imaging NCIT:C16809 NCI Thesaurus (NCIT)
CT is an acceptable substitute where MRI is unavailable and was the modality in at least one cohort member, but it is not separately curated: NCIT's CT terms describe the procedure without the neuro qualifier that would make the entry more informative than this one.
Show evidence (1 reference)
PMID:39174524 SUPPORT Human Clinical
"These imaging studies highlight the heterogenous neuroanatomical manifestations of biallelic DENND5A variants, but certain features including volume loss, ventriculomegaly, and hypoplasia of the corpus callosum appear more frequently"
States both what imaging reliably shows and that it is heterogeneous - the reason it narrows the differential without closing it.
Exome or Genome Sequencing
The diagnosis is molecular. There is no biochemical marker and the neuroimaging phenotype, while characteristic, overlaps enough with OCLN-related disease, the tubulinopathies, LIS1-related lissencephaly and congenital infection that imaging alone does not settle it.
Whole Exome Sequencing NCIT:C101295 NCI Thesaurus (NCIT)
Show evidence (1 reference)
PMID:39174524 SUPPORT Human Clinical
"there is a selective involvement of the cortex added to the presence of periventricular calcifications, a common association that brings cytomegalovirus- induced brain malformations into the differential but aligns with pseudo-TORCH syndrome diagnostic criteria in the absence of congenital infection"
Documents the imaging differential that makes molecular confirmation necessary rather than confirmatory.
📊

Prevalence

1
Worldwide
Cases In Literature Ultra Rare
24 individuals from 22 families in the definitive 2024 cohort, which incorporated the families reported earlier. No population prevalence estimate exists.
Show evidence (1 reference)
PMID:39174524 SUPPORT Human Clinical
"we identified a cohort of 24 people (11F, 13M, mean age = 9.0 years, SD = 6.0) from 22 families with biallelic DENND5A variants"
The total reported case count as of the 2024 study.
🔀

Differential Diagnoses

4

Conditions with similar clinical presentations that must be differentiated from DENND5A-Related Developmental and Epileptic Encephalopathy:

Congenital cytomegalovirus infection Not Yet Curated MONDO:0017409
Overlapping Features The differential a clinician actually faces first. Periventricular calcifications with selective cortical involvement is a classic congenital-infection pattern, and the DENND5A imaging phenotype reproduces it closely enough that the paper names the confusion explicitly.
Distinguishing Features
  • Absence of congenital infection on serology or PCR. The same constellation then aligns with pseudo-TORCH diagnostic criteria - which is to say, with a genetic rather than an infectious cause.
Show evidence (1 reference)
PMID:39174524 SUPPORT Human Clinical
"there is a selective involvement of the cortex added to the presence of periventricular calcifications, a common association that brings cytomegalovirus- induced brain malformations into the differential but aligns with pseudo-TORCH syndrome diagnostic criteria in the absence of congenital infection"
Names congenital CMV as the differential the imaging raises, and the finding that resolves it.
Tubulinopathies
Overlapping Features Tubulin gene variants produce overlapping cortical malformation phenotypes and belong in the same imaging differential.
Distinguishing Features
  • The tubulinopathies show a classic dysgyria pattern that the DENND5A cohort lacks.
  • The tubulinopathies are not associated with calcifications, which are present in DENND5A.
Show evidence (1 reference)
PMID:39174524 SUPPORT Human Clinical
"Variants in tubulin genes also result in overlapping phenotypes47, but our cases lack the classic dysgyria pattern and instead are observed in the context of occipital pachygyria and differ in that our cases are associated with calcifications"
States the overlap and both discriminating features.
🧫

Experimental Models

2
DENND5A knockout human iPSC-derived neural rosettes IPSC_DERIVED_MODEL
Neural rosettes formed from wild-type and CRISPR/Cas9 DENND5A knockout human iPSCs. A rosette is a polarized in vitro model of early neural development with a central F-actin-rich lumen standing in for the ventricular surface, which is what makes the mitotic spindle angle measurable at all. This is the system that produced the disorder's central quantitative finding.
Publication
DENND5A knockout human iPSC-derived neural progenitor cells IPSC_DERIVED_MODEL
Neural progenitors differentiated from wild-type and DENND5A knockout human iPSCs, validated as SOX1, SOX2 and Nestin positive. Used for proliferation counts and for the premature differentiation assay.
Publication
🐁

Animal Models

2
DENND5A knock-in mouse
A knock-in line in which full-length DENND5A protein is not expressed. Used for structural neuroimaging, adult subventricular zone histology and chemically provoked seizure susceptibility.
Species
Mouse
Genotype
homozygous DENND5A knock-in (no full-length protein expressed)
Publication
dennd5a F0 CRISPR knockout zebrafish
F0 crispants carrying biallelic dennd5a mutations, phenotyped morphologically at 5 days post fertilization. The value of this model is that it reproduces the two structural findings - small head, large ventricle - in a second species and at a whole-organism developmental scale.
Species
Zebrafish
Genotype
biallelic dennd5a CRISPR/Cas9 F0 knockout (crispant)
Publication
{ }

Source YAML

click to show
name: DENND5A-Related Developmental and Epileptic Encephalopathy
creation_date: "2026-08-20T09:30:00Z"
category: Mendelian
synonyms:
- Developmental and epileptic encephalopathy 49
- DEE49
- EIEE49
- Epileptic encephalopathy, early infantile, 49
- DENND5A deficiency
description: >-
  DENND5A-related developmental and epileptic encephalopathy (DEE49) is an autosomal
  recessive disorder caused by biallelic loss-of-function variants in DENND5A, a
  DENN-domain protein that is both a candidate Rab guanine nucleotide exchange factor and
  a binding partner of the Crumbs apical polarity proteins MUPP1 and PALS1. The mechanism
  is developmental rather than primarily electrical: without DENND5A, apical neural
  progenitors misorient their mitotic spindles away from the ventricular surface, divide
  asymmetrically instead of symmetrically, and prematurely exit the cell cycle to
  differentiate into neurons. The progenitor pool is depleted before neurogenesis is
  complete, producing primary microcephaly, ventriculomegaly, cortical malformation and
  corpus callosum dysgenesis; the mispositioned, prematurely born neurons form aberrant
  connections and seizures follow. Cerebral calcifications and coarse facial features
  were part of the original clinical description.
disease_term:
  preferred_term: developmental and epileptic encephalopathy, 49
  term:
    id: MONDO:0015002
    label: developmental and epileptic encephalopathy, 49
parents:
- Epilepsy
- Neurological Disease
inheritance:
- name: Autosomal recessive
  inheritance_term:
    preferred_term: Autosomal recessive inheritance
    term:
      id: HP:0000007
      label: Autosomal recessive inheritance
  description: >-
    Biallelic - homozygous in consanguineous families or compound heterozygous. In the
    24-person cohort, 14 individuals were homozygous and 10 compound heterozygous. No
    point mutation was found homozygous in gnomAD, which is the population-genetic
    argument that two damaged alleles are not tolerated.
  evidence:
  - reference: PMID:27866705
    reference_title: "Epileptic Encephalopathy Caused by Mutations in the Guanine Nucleotide Exchange Factor DENND5A."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "we have identified an epileptic encephalopathy additionally featuring
      cerebral calcifications and coarse facial features caused by recessive
      loss-of-function mutations in DENND5A"
    explanation: >-
      The founding gene-disease report, establishing recessive loss of function.
  - reference: PMID:39174524
    reference_title: "Loss of symmetric cell division of apical neural progenitors drives DENND5A-related developmental and epileptic encephalopathy."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "None of the DENND5A point mutations in the cohort were found in the
      homozygous state among 140,000 individuals on gnomAD, a database that removes
      individuals affected by severe pediatric disease, indicating that biallelic
      pathogenic variants are likely incompatible with normal development"
    explanation: >-
      Population-genetic support for the recessive model and for the severity of the
      biallelic state.

pathophysiology:

- name: Biallelic DENND5A Loss-of-Function Variants
  biological_scale: MOLECULAR
  description: >-
    The initiating lesion. Thirty unique variants have been reported across 22 families,
    spread over the whole protein rather than clustering in one domain: nine in the DENN
    domain, two in RUN1, six in PLAT, four in RUN2 and four in the linkers, plus copy
    number and splice-site variants. That distribution is itself mechanistically
    informative - it is what a loss-of-function disorder looks like, as opposed to the
    domain-restricted clustering seen in gain-of-function DEEs.
  genes:
  - preferred_term: DENND5A
    term:
      id: hgnc:19344
      label: DENND5A
  evidence:
  - reference: PMID:39174524
    reference_title: "Loss of symmetric cell division of apical neural progenitors drives DENND5A-related developmental and epileptic encephalopathy."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Thirty unique DENND5A variants were identified across the 14 homozygous and
      10 compound heterozygous individuals"
    explanation: >-
      Establishes the size and allelic architecture of the reported variant spectrum.
  - reference: PMID:39174524
    reference_title: "Loss of symmetric cell division of apical neural progenitors drives DENND5A-related developmental and epileptic encephalopathy."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "The coding variants span the length of the protein including nine in the
      DENN domain, two in the RUN1 domain, six in the PLAT domain, four in the RUN2
      domain, and four in predicted linker regions between the folded modules"
    explanation: >-
      Documents that variants are distributed across the protein rather than clustered,
      consistent with loss of function.
  downstream:
  - target: Reduced DENND5A Protein
    causal_link_type: DIRECT
    description: >-
      Every patient-derived cell line examined shows less DENND5A protein, whatever the
      variant class.

- name: Reduced DENND5A Protein
  biological_scale: MOLECULAR
  description: >-
    The convergent proximal consequence. Cells from five cohort members - three
    iPSC-derived neural progenitor lines and two immortalized lymphoblast lines, spanning
    frameshift, nonsense and missense variants - all show reduced DENND5A protein. The
    reduction is post-transcriptional: patient mRNA levels do not differ significantly
    from controls, so the protein is lost after it is made rather than because the
    transcript is absent. This node is curated separately from the variants above because
    the protein and transcript measurements come apart, and it is the protein measurement
    that carries the loss-of-function claim.
  cell_types:
  - preferred_term: neural progenitor cell
    term:
      id: CL:0011020
      label: neural progenitor cell
  evidence:
  - reference: PMID:39174524
    reference_title: "Loss of symmetric cell division of apical neural progenitors drives DENND5A-related developmental and epileptic encephalopathy."
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: "All patient-derived cells exhibit a reduction in DENND5A protein
      (Supplementary Fig. 2a, b), supporting that disease phenotypes are a result of
      protein loss of function"
    explanation: >-
      The direct measurement establishing protein loss of function across variant classes.
  - reference: PMID:39174524
    reference_title: "Loss of symmetric cell division of apical neural progenitors drives DENND5A-related developmental and epileptic encephalopathy."
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: "A rather poor correlation between DENND5A mRNA and protein levels was
      observed as DENND5A mRNA expression from patient-derived cells did not differ
      significantly from controls"
    explanation: >-
      Locates the defect after transcription, which is why the protein and transcript
      claims are curated as separate measurements.
  downstream:
  - target: Loss of DENND5A-MUPP1/PALS1 Association at the Apical Membrane
    causal_link_type: DIRECT
    description: >-
      Less protein means less of the polarity-complex interaction that follows.
  - target: Impaired Rab-Directed Membrane Trafficking
    causal_link_type: DIRECT
    description: >-
      The second, parallel arm - the DENN domain's own predicted enzymatic function.

- name: Loss of DENND5A-MUPP1/PALS1 Association at the Apical Membrane
  biological_scale: MOLECULAR
  description: >-
    DENND5A binds MUPP1 and PALS1, two components of the Crumbs apical polarity complex
    that is required for symmetric division of neural progenitors. The interaction is
    conformation-dependent: full-length DENND5A binds these partners only weakly, because
    the binding region makes intramolecular contacts with the DENN domain, and a
    conformational change is needed to expose it. Losing DENND5A therefore removes a
    conformationally gated link into the apical polarity machinery, which is the point at
    which this trafficking protein becomes a developmental one.
  protein_complexes:
  - preferred_term: Crumbs apical polarity complex (MUPP1-PALS1)
  biological_processes:
  - preferred_term: establishment or maintenance of cell polarity
    term:
      id: GO:0007163
      label: establishment or maintenance of cell polarity
    modifier: DECREASED
  cellular_components:
  - preferred_term: apical plasma membrane
    term:
      id: GO:0016324
      label: apical plasma membrane
  evidence:
  - reference: PMID:39174524
    reference_title: "Loss of symmetric cell division of apical neural progenitors drives DENND5A-related developmental and epileptic encephalopathy."
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: "Mass spectrometry of purified proteins revealed members of the Crb polarity
      complex, MUPP1, and PALS1, as major DENND5A binding partners"
    explanation: >-
      Identifies the polarity-complex partners by unbiased proteomics.
  - reference: PMID:39174524
    reference_title: "Loss of symmetric cell division of apical neural progenitors drives DENND5A-related developmental and epileptic encephalopathy."
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: "This suggests a conformational change in DENND5A is necessary to expose the
      binding site for MUPP1/PALS1. In fact, full-length DENND5A has limited interaction
      with these proteins"
    explanation: >-
      Establishes that the interaction is gated by DENND5A's conformation, which is what
      the R710H variant later exploits.
  - reference: PMID:39174524
    reference_title: "Loss of symmetric cell division of apical neural progenitors drives DENND5A-related developmental and epileptic encephalopathy."
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: "We demonstrate that DENND5A interacts with Pals1/MUPP1, components of the
      Crumbs apical polarity complex required for symmetrical division of neural
      progenitor cells"
    explanation: >-
      Links the interaction to the specific cellular process the disorder disrupts.
  downstream:
  - target: Mitotic Spindle Misorientation in Apical Neural Progenitors
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    description: >-
      How the polarity-complex interaction is transduced to the spindle is not
      established. DENND5A is not required to deliver MUPP1/PALS1 to the apical membrane -
      those proteins still localize apically in knockout rosettes - so the route from
      interaction to spindle angle runs through some other, unidentified step.

- name: Impaired Rab-Directed Membrane Trafficking
  biological_scale: MOLECULAR
  description: >-
    The second, older mechanistic thread, and the one the gene is named for. DENND5A
    carries a DENN domain, the module that confers guanine nucleotide exchange factor
    activity toward Rab GTPases, and two RUN domains through which it binds active Rab6
    and sorting nexin 1. Structural modeling qualifies this: the predicted Rab enzymatic
    site may be occluded by the DENN-RUN1/PLAT interaction in the closed conformation,
    while Rab6 binding to RUN1 needs no conformational change - so the two functions are
    predicted to require different conformations of the same protein. This node is kept
    separate from the polarity arm rather than merged into it, because no source available
    to this entry shows that trafficking loss is what causes the spindle defect.
  molecular_functions:
  - preferred_term: guanyl-nucleotide exchange factor activity
    term:
      id: GO:0005085
      label: guanyl-nucleotide exchange factor activity
    modifier: DECREASED
  biological_processes:
  - preferred_term: vesicle-mediated transport
    term:
      id: GO:0016192
      label: vesicle-mediated transport
    modifier: DECREASED
  - preferred_term: retrograde transport, endosome to Golgi
    term:
      id: GO:0042147
      label: retrograde transport, endosome to Golgi
  evidence:
  - reference: PMID:27866705
    reference_title: "Epileptic Encephalopathy Caused by Mutations in the Guanine Nucleotide Exchange Factor DENND5A."
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: "DENND5A contains a DENN domain, an evolutionarily ancient enzymatic module
      conferring guanine nucleotide exchange factor (GEF) activity to multiple proteins
      serving as GEFs for Rabs, which are key regulators of membrane trafficking"
    explanation: >-
      Establishes the DENN domain's expected enzymatic role in membrane trafficking.
  - reference: PMID:39174524
    reference_title: "Loss of symmetric cell division of apical neural progenitors drives DENND5A-related developmental and epileptic encephalopathy."
    supports: SUPPORT
    evidence_source: COMPUTATIONAL
    snippet: "we aligned the co-crystal structure of DENND1B and Rab35 with the predicted
      DENND5A structure and found that the predicted Rab enzymatic site in DENND5A may be
      occluded by interactions between the DENN and RUN1 (RPIP8, UNC-14 and NESCA)/PLAT
      (Polycystin-1, Lipoxygenase, Alpha-Toxin) domains"
    explanation: >-
      Curated PARTIAL: a structural prediction that qualifies the GEF assignment rather
      than a measurement of exchange activity. No source available to this entry reports
      DENND5A GEF activity assayed directly against a Rab substrate.
  downstream:
  - target: Neurotrophin Receptor Upregulation and Enhanced Downstream Signaling
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    description: >-
      Knockdown raises neurotrophin receptor levels, but by what trafficking step is not
      identified.

- name: Neurotrophin Receptor Upregulation and Enhanced Downstream Signaling
  biological_scale: CELLULAR
  description: >-
    In the founding study, knocking DENND5A down altered neuronal development, and the
    change appeared to be mediated by an increase in neurotrophin receptors and hence in
    downstream signaling. This is a knockdown-derived account from 2016 and has not been
    reproduced in the patient-derived systems used in the 2024 cohort study, so it is
    curated as a parallel arm reaching the same developmental endpoint rather than as a
    step in the spindle chain.
  biological_processes:
  - preferred_term: neurotrophin TRK receptor signaling pathway
    term:
      id: GO:0048011
      label: neurotrophin TRK receptor signaling pathway
    modifier: INCREASED
  evidence:
  - reference: PMID:27866705
    reference_title: "Epileptic Encephalopathy Caused by Mutations in the Guanine Nucleotide Exchange Factor DENND5A."
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: "Knockdown of DENND5A leads to striking alterations in neuronal development.
      Mechanistically, these changes appear to result from upregulation of neurotrophin
      receptors, leading to enhanced downstream signaling"
    explanation: >-
      The knockdown result and the receptor-upregulation account offered for it. The
      source's own hedge - "appear to result from" - is preserved in the description.
  downstream:
  - target: Premature Neuronal Differentiation and Cell Cycle Exit
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    description: >-
      Both arms converge on altered neuronal development; the intermediates on this one
      are not identified.

- name: Mitotic Spindle Misorientation in Apical Neural Progenitors
  biological_scale: CELLULAR
  description: >-
    The rate-limiting cellular defect. In human iPSC-derived neural rosettes - a polarized
    in vitro model of early neural development - the angle between the cleavage plane and
    the apical surface collapses when DENND5A is absent. Wild-type progenitors divide with
    a mean spindle angle of 57.1 degrees, close to the plane that gives both daughters
    equal access to the apical surface; knockout progenitors divide at 26.0 degrees, and
    an overwhelming majority fall below 45 degrees.
  cell_types:
  - preferred_term: apical radial glial cell
    term:
      id: CL:0000681
      label: radial glial cell
  biological_processes:
  - preferred_term: establishment of mitotic spindle orientation
    term:
      id: GO:0000132
      label: establishment of mitotic spindle orientation
    modifier: DECREASED
  cellular_components:
  - preferred_term: mitotic spindle
    term:
      id: GO:0072686
      label: mitotic spindle
  evidence:
  - reference: PMID:39174524
    reference_title: "Loss of symmetric cell division of apical neural progenitors drives DENND5A-related developmental and epileptic encephalopathy."
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: "the spindle angle among cells dividing within WT (M = 57.1°, Mdn = 65.4°, SD
      = 25.9) and KO (M = 26.0°, Mdn = 20.1°, SD = 19.0) rosettes differed significantly"
    explanation: >-
      The quantitative spindle-angle measurement in human iPSC-derived neural rosettes.
  - reference: PMID:39174524
    reference_title: "Loss of symmetric cell division of apical neural progenitors drives DENND5A-related developmental and epileptic encephalopathy."
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: "These phenotypes result from misalignment of the mitotic spindle in apical
      neural progenitors"
    explanation: >-
      The authors' own placement of spindle misalignment as the causal step.
  downstream:
  - target: Loss of Symmetric Proliferative Division
    causal_link_type: DIRECT
    description: >-
      Spindle angle sets the division plane, and hence whether both daughters retain apical
      contact.

- name: Loss of Symmetric Proliferative Division
  biological_scale: CELLULAR
  description: >-
    An oblique cleavage plane means only one daughter keeps contact with the apical
    ventricular surface and inherits the apical determinants MUPP1 and PALS1. The other is
    displaced basally and receives less of the stem-cell-niche signal, so it is biased
    toward commitment. The division that should have produced two progenitors produces one
    progenitor and one committed cell.
  cell_types:
  - preferred_term: apical radial glial cell
    term:
      id: CL:0000681
      label: radial glial cell
  biological_processes:
  - preferred_term: symmetric cell division
    term:
      id: GO:0098725
      label: symmetric cell division
    modifier: DECREASED
  - preferred_term: asymmetric cell division
    term:
      id: GO:0008356
      label: asymmetric cell division
    modifier: INCREASED
  evidence:
  - reference: PMID:39174524
    reference_title: "Loss of symmetric cell division of apical neural progenitors drives DENND5A-related developmental and epileptic encephalopathy."
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: "indicating that DENND5A KO results in increased levels of oblique asymmetric
      cell divisions and the ability for apical progenitors to self-renew is severely
      compromised"
    explanation: >-
      States the division-mode shift and its consequence for self-renewal.
  - reference: PMID:39174524
    reference_title: "Loss of symmetric cell division of apical neural progenitors drives DENND5A-related developmental and epileptic encephalopathy."
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: "Cells lacking DENND5A orient away from the proliferative apical domain
      surrounding the ventricles, biasing daughter cells towards a more fate-committed
      state"
    explanation: >-
      Connects loss of apical contact to the fate bias in the daughter cells.
  downstream:
  - target: Premature Neuronal Differentiation and Cell Cycle Exit
    causal_link_type: DIRECT
    description: >-
      The committed daughter differentiates instead of dividing again.
  - target: Neural Progenitor Pool Depletion
    causal_link_type: DIRECT
    description: >-
      Each non-self-renewing division removes a progenitor from the pool.

- name: Premature Neuronal Differentiation and Cell Cycle Exit
  biological_scale: CELLULAR
  description: >-
    Knockout progenitors do not merely divide differently, they are inherently more likely
    to leave the cycle. One day after passaging into progenitor maintenance medium -
    conditions meant to keep them undifferentiated - 47.29 percent of knockout cells had
    developed neuronal processes against 10.67 percent of wild-type. The same shift is
    present in the adult mouse: knock-in animals have a higher proportion of NeuN-positive
    post-mitotic neurons in the subventricular zone. This is a propensity of the cells
    themselves, which is why it is curated as its own node with an input from the division
    defect rather than only as its consequence.
  cell_types:
  - preferred_term: neural progenitor cell
    term:
      id: CL:0011020
      label: neural progenitor cell
  biological_processes:
  - preferred_term: neuron differentiation
    term:
      id: GO:0030182
      label: neuron differentiation
    modifier: INCREASED
  - preferred_term: cell fate commitment
    term:
      id: GO:0045165
      label: cell fate commitment
    modifier: INCREASED
  evidence:
  - reference: PMID:39174524
    reference_title: "Loss of symmetric cell division of apical neural progenitors drives DENND5A-related developmental and epileptic encephalopathy."
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: "Our results suggest that DENND5A expression promotes stemness and its loss
      drives cell cycle exit and premature differentiation into neuronal phenotypes"
    explanation: >-
      The authors' summary of the differentiation phenotype across their in vitro and in
      vivo measurements.
  - reference: PMID:39174524
    reference_title: "Loss of symmetric cell division of apical neural progenitors drives DENND5A-related developmental and epileptic encephalopathy."
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: "Human induced pluripotent stem cells lacking DENND5A fail to undergo
      symmetric cell division with an inherent propensity to differentiate into neurons"
    explanation: >-
      States the propensity as inherent to the cells, not only a consequence of the
      division geometry.
  - reference: PMID:39174524
    reference_title: "Loss of symmetric cell division of apical neural progenitors drives DENND5A-related developmental and epileptic encephalopathy."
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: "KI mice have a significantly higher percentage of post-mitotic neurons
      expressing NeuN compared to WT mice"
    explanation: >-
      In vivo corroboration in the knock-in mouse subventricular zone.
  downstream:
  - target: Neural Progenitor Pool Depletion
    causal_link_type: DIRECT
    description: >-
      Cells that differentiate are no longer available to divide.
  - target: Aberrant Positioning and Connectivity of Prematurely Born Neurons
    causal_link_type: DIRECT
    description: >-
      Neurons born early and in the wrong place make the wrong contacts.

- name: Neural Progenitor Pool Depletion
  biological_scale: CELLULAR
  description: >-
    The two upstream defects - fewer self-renewing divisions and more cells leaving the
    cycle - both subtract from the same pool, and the pool is measurably smaller. Equal
    numbers of wild-type and knockout progenitors plated together diverge within two days:
    1008 wild-type cells per well against 614 knockout, and by 72 hours 1685 against 683.
    Wild-type numbers climb while knockout numbers stay nearly flat.
  cell_types:
  - preferred_term: neural progenitor cell
    term:
      id: CL:0011020
      label: neural progenitor cell
  biological_processes:
  - preferred_term: neural precursor cell proliferation
    term:
      id: GO:0061351
      label: neural precursor cell proliferation
    modifier: DECREASED
  evidence:
  - reference: PMID:39174524
    reference_title: "Loss of symmetric cell division of apical neural progenitors drives DENND5A-related developmental and epileptic encephalopathy."
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: "WT NPCs then rapidly increased in number whereas the number of KO NPCs
      remained relatively stable"
    explanation: >-
      The proliferation divergence between wild-type and knockout progenitors.
  downstream:
  - target: Shortened Period of Neurogenesis
    causal_link_type: DIRECT
    description: >-
      Fewer progenitors, entering the pool later and leaving it earlier, means neurogenesis
      runs out sooner.

- name: Shortened Period of Neurogenesis
  biological_scale: TISSUE
  description: >-
    The developmental endpoint of the progenitor arithmetic. Neurogenesis in the developing
    cortex is bounded by how long a progenitor pool of sufficient size persists; when the
    pool is depleted early, the window closes early and fewer neurons, of fewer lineages,
    are produced.
  biological_processes:
  - preferred_term: neurogenesis
    term:
      id: GO:0022008
      label: neurogenesis
    modifier: DECREASED
  - preferred_term: cerebral cortex development
    term:
      id: GO:0021987
      label: cerebral cortex development
    modifier: DECREASED
  evidence:
  - reference: PMID:39174524
    reference_title: "Loss of symmetric cell division of apical neural progenitors drives DENND5A-related developmental and epileptic encephalopathy."
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: "biasing daughter cells towards a more fate-committed state, ultimately
      shortening the period of neurogenesis"
    explanation: >-
      Names the shortened neurogenic period as the outcome of the fate bias.
  - reference: PMID:39174524
    reference_title: "Loss of symmetric cell division of apical neural progenitors drives DENND5A-related developmental and epileptic encephalopathy."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Ultimately, this results in a shortened period of neurogenesis which leads to
      microcephaly and/or observable abnormalities in gray and white matter structures"
    explanation: >-
      The authors' own statement of the link from shortened neurogenesis to the structural
      brain phenotype.
  downstream:
  - target: Reduced Brain Volume and Cortical Malformation
    causal_link_type: DIRECT
    description: >-
      Too few neurons, produced over too short a window.

- name: Reduced Brain Volume and Cortical Malformation
  biological_scale: TISSUE
  description: >-
    The structural phenotype: microcephaly, reduced white matter volume, pachygyria with
    an occipital predominance, basal ganglia and diencephalic-mesencephalic junction dysplasia,
    corpus callosum agenesis or hypoplasia, and striatal and periventricular calcifications.
    Corpus callosum volume in the cohort was normal, thin or absent, never increased - a
    detail that distinguishes this from the LIS1 tubulinopathy differential.
  locations:
  - preferred_term: cerebral cortex
    term:
      id: UBERON:0000956
      label: cerebral cortex
  evidence:
  - reference: PMID:39174524
    reference_title: "Loss of symmetric cell division of apical neural progenitors drives DENND5A-related developmental and epileptic encephalopathy."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "cortical malformations, particularly with pachygyria involving the occipital
      lobes, a reduced volume of the white matter with associated striatal and
      periventricular calcifications and ventriculomegaly, agenesis or severe
      dysplasia/hypoplasia of the corpus callosum"
    explanation: >-
      The structural MRI phenotype as reported in the cohort.
  - reference: PMID:39174524
    reference_title: "Loss of symmetric cell division of apical neural progenitors drives DENND5A-related developmental and epileptic encephalopathy."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "These imaging studies highlight the heterogenous neuroanatomical
      manifestations of biallelic DENND5A variants, but certain features including volume
      loss, ventriculomegaly, and hypoplasia of the corpus callosum appear more frequently"
    explanation: >-
      Records both the heterogeneity and the recurrent features.
  downstream:
  - target: Compensatory Ventriculomegaly
    causal_link_type: DIRECT
    description: >-
      The authors read the ventricular enlargement as filling volume the missing neurons
      would have occupied.

- name: Compensatory Ventriculomegaly
  biological_scale: TISSUE
  description: >-
    Ventricular enlargement is present in 15 of 24 individuals and is reproduced in the
    knock-in mouse by 7T MRI. The 2024 study reads it as compensatory - space vacated by
    the reduced neuronal volume - rather than as an independent obstructive or resorptive
    process. That reading is an interpretation offered by the source, not a measurement,
    and is recorded as such.
  evidence:
  - reference: PMID:39174524
    reference_title: "Loss of symmetric cell division of apical neural progenitors drives DENND5A-related developmental and epileptic encephalopathy."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "The reduced volume of neurons likely leads to compensatory ventriculomegaly"
    explanation: >-
      The compensatory interpretation, hedged by the source with "likely" and preserved
      here as such.
  - reference: PMID:39174524
    reference_title: "Loss of symmetric cell division of apical neural progenitors drives DENND5A-related developmental and epileptic encephalopathy."
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: "In vivo 7T MRI scans revealed that DENND5A KI mice have significantly
      enlarged lateral ventricles (MWT = 4.8 mm3, MKI = 6.6 mm3, SDWT = 1.3, SDKI = 2.4,
      two-tailed Mann-Whitney U, Z = −2.117, p = 0.034), consistent with ventriculomegaly"
    explanation: >-
      Quantitative in vivo reproduction of the ventriculomegaly in the mouse model.

- name: Aberrant Positioning and Connectivity of Prematurely Born Neurons
  biological_scale: TISSUE
  description: >-
    Neurons born too early and displaced from the ventricular surface end up in the wrong
    laminar position and, where they escape apoptosis, form synaptic contacts they should
    not have. This is the proposed bridge from the developmental defect to the epilepsy,
    and it is the least directly evidenced step in the chain: it is asserted in the
    authors' disease model, not measured. The edge into seizure generation is marked
    accordingly.
  cell_types:
  - preferred_term: neuron
    term:
      id: CL:0000540
      label: neuron
  evidence:
  - reference: PMID:39174524
    reference_title: "Loss of symmetric cell division of apical neural progenitors drives DENND5A-related developmental and epileptic encephalopathy."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "improperly positioned prematurely-born neurons that do not undergo apoptosis
      and form aberrant synaptic contacts results in seizures that can further adversely
      affect development"
    explanation: >-
      Curated PARTIAL: this is the proposed disease model, stated in the discussion, not a
      measurement of synaptic connectivity in patient or model tissue.
  downstream:
  - target: Seizure Generation and Developmental and Epileptic Encephalopathy
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    description: >-
      No source available to this entry measures excitation-inhibition balance, network
      synchrony or intrinsic excitability in DENND5A-deficient neurons. The step from
      aberrant connectivity to seizures is therefore inferential.

- name: Seizure Generation and Developmental and Epileptic Encephalopathy
  biological_scale: ORGANISM
  conforms_to: "epilepsy_excitation_inhibition_imbalance#Recurrent Unprovoked Seizures"
  description: >-
    Recurrent, usually drug-resistant seizures in 21 of 24 individuals, with focal to
    bilateral tonic-clonic the most common type. Seizures then act back on development, the
    defining feature of a developmental and epileptic encephalopathy. Conformance attaches
    at the module's Recurrent Unprovoked Seizures node - the clinical endpoint - and not at
    the upstream excitation-inhibition or hyperexcitability nodes, because no ion-channel or
    synaptic measurement exists for this disorder to support those. The developmental
    encephalopathy here has an independent origin in the neurogenesis defect and is not
    solely seizure-driven.
  evidence:
  - reference: PMID:39174524
    reference_title: "Loss of symmetric cell division of apical neural progenitors drives DENND5A-related developmental and epileptic encephalopathy."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "The phenotypes observed in more than 50% of individuals with biallelic
      DENND5A variants were seizures (21/24), microcephaly (16/24), ventriculomegaly
      (15/24), hypertonia (14/24), cerebral hypoplasia (13/24), and hyperreflexia (13/24)"
    explanation: >-
      Quantifies seizures as the most frequent feature of the cohort.
  - reference: PMID:39174524
    reference_title: "Loss of symmetric cell division of apical neural progenitors drives DENND5A-related developmental and epileptic encephalopathy."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Developmental and epileptic encephalopathies (DEEs) feature altered brain
      development, developmental delay and seizures, with seizures exacerbating
      developmental delay"
    explanation: >-
      States the DEE construct - seizures acting back on development - that this endpoint
      instantiates.
  notes: >-
    Three of the 24 individuals had no seizures at all, so the seizure phenotype is not
    obligate even though the disorder is classified as a DEE. Those individuals also had
    milder neurological findings, which is consistent with the variant-class severity
    gradient recorded in the genetic section.

mechanistic_hypotheses:
- hypothesis_group_id: apical_polarity_spindle_orientation_model
  status: CANONICAL
  description: >-
    Loss of DENND5A removes a conformationally gated link to the MUPP1/PALS1 apical
    polarity complex, apical progenitors misorient their mitotic spindles, symmetric
    proliferative division is lost, the progenitor pool is depleted early, and neurogenesis
    is cut short - producing microcephaly and cortical malformation, with seizures arising
    from the mispositioned neurons. This is the account with quantitative support in human
    iPSC-derived cells and corroboration in mouse and zebrafish.
  evidence:
  - reference: PMID:39174524
    reference_title: "Loss of symmetric cell division of apical neural progenitors drives DENND5A-related developmental and epileptic encephalopathy."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "This study provides a mechanism for DENND5A-related DEE that may be
      generalizable to other developmental conditions and provides variant-specific
      clinical information for physicians and families"
    explanation: >-
      The authors' framing of this as the mechanism for the disorder.

- hypothesis_group_id: rab_trafficking_neurotrophin_model
  status: ALTERNATIVE
  description: >-
    Loss of DENND5A's Rab-directed trafficking function raises neurotrophin receptor
    abundance and hence downstream signaling, and it is that signaling change that alters
    neuronal development. This was the founding account and it remains the one predicted by
    the protein's domain architecture, but it rests on knockdown experiments and has not
    been re-examined in the patient-derived neural progenitor and rosette systems that
    established the polarity mechanism. The two accounts are not mutually exclusive - a
    single protein with two conformations may serve both - and the trafficking arm is
    retained here rather than retired.
  evidence:
  - reference: PMID:27866705
    reference_title: "Epileptic Encephalopathy Caused by Mutations in the Guanine Nucleotide Exchange Factor DENND5A."
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: "Mechanistically, these changes appear to result from upregulation of
      neurotrophin receptors, leading to enhanced downstream signaling"
    explanation: >-
      The founding mechanistic proposal, in the source's own hedged wording.

phenotypes:

- category: Neurological
  name: Global Developmental Delay
  description: >-
    The "D" in this developmental and epileptic encephalopathy, and the single most frequent
    feature of the disorder - more frequent than the seizures. Twenty-three of the 24
    reported individuals presented with or had a history of global developmental delay; the
    one exception, participant 8, carries biallelic missense variants and is also the only
    cohort member with no intellectual disability. That single exception is what keeps this
    VERY_FREQUENT rather than OBLIGATE.
  frequency: VERY_FREQUENT
  phenotype_term:
    preferred_term: Global developmental delay
    term:
      id: HP:0001263
      label: Global developmental delay
  evidence:
  - reference: PMID:39174524
    reference_title: "Loss of symmetric cell division of apical neural progenitors drives DENND5A-related developmental and epileptic encephalopathy."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Failure to meet key developmental milestones was almost universal in the
      cohort, evidenced by the fact that all but one (participant 8; p.K485E/p.R1159W)
      presented with or had a history of global developmental delay"
    explanation: >-
      23/24 is 96 percent, in the VERY_FREQUENT band (80-99 percent). The source names both
      the count and the single exception, so the band is derived rather than estimated.

- category: Neurological
  name: Intellectual Disability
  description: >-
    Assessed in the cohort members old enough for it - after age 5. The severity
    distribution is skewed hard toward the severe end: 9 severe, 3 profound, 2 moderate, and
    a single individual with none. Curated as the general term with the distribution in the
    evidence rather than as four separate severity phenotypes, because the source reports
    one assessment per patient across a spectrum rather than co-occurring findings.
  frequency: VERY_FREQUENT
  phenotype_term:
    preferred_term: Intellectual disability
    term:
      id: HP:0001249
      label: Intellectual disability
  evidence:
  - reference: PMID:39174524
    reference_title: "Loss of symmetric cell division of apical neural progenitors drives DENND5A-related developmental and epileptic encephalopathy."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Among cohort members assessed after age 5, 9 had severe intellectual
      disability (ID), profound ID was reported for 3 individuals, moderate ID was observed
      in 2 cases, and one participant (8) had no ID"
    explanation: >-
      14 of the 15 assessed individuals had intellectual disability, which is 93 percent and
      falls in the VERY_FREQUENT band. Note the denominator is the assessed subset, not the
      whole cohort - the band is over those old enough to be assessed.

- category: Neurological
  name: Inability to Walk Independently
  description: >-
    Only 8 of 24 individuals could walk independently, and 11 of 24 could reach for and
    grasp objects. Motor capability tracks two things in this cohort: it is significantly
    worse in those with microcephaly, and significantly better in those with biallelic
    missense variants than in those carrying a truncating allele.
  frequency: FREQUENT
  phenotype_term:
    preferred_term: Inability to walk
    term:
      id: HP:0002540
      label: Inability to walk
  evidence:
  - reference: PMID:39174524
    reference_title: "Loss of symmetric cell division of apical neural progenitors drives DENND5A-related developmental and epileptic encephalopathy."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Eight of twenty-four individuals (33%) could walk independently and 11/24
      (46%) were able to reach for and grasp objects"
    explanation: >-
      The complement, 16/24 or 67 percent, falls in the FREQUENT band. The band is derived
      from the stated count rather than quoted directly, which is why the derivation is
      spelled out here.
  - reference: PMID:39174524
    reference_title: "Loss of symmetric cell division of apical neural progenitors drives DENND5A-related developmental and epileptic encephalopathy."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Motor capabilities were more severely affected in those with microcephaly
      (MMicro = 3.2, MNo micro = 7.2, SDMicro = 3.5, SDNo micro = 3.4, two-tailed
      Mann-Whitney U, Z = −2.55, p = 0.011"
    explanation: >-
      Quantifies the association between microcephaly and motor outcome, which is the one
      within-cohort predictor of motor severity the study reports besides variant class.

- category: Neurological
  name: Seizures
  description: >-
    Present in 21 of 24 reported individuals. Focal to bilateral tonic-clonic is the most
    common type, and most focal seizures impair awareness.
  frequency: VERY_FREQUENT
  phenotype_term:
    preferred_term: Seizure
    term:
      id: HP:0001250
      label: Seizure
  evidence:
  - reference: PMID:39174524
    reference_title: "Loss of symmetric cell division of apical neural progenitors drives DENND5A-related developmental and epileptic encephalopathy."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "The phenotypes observed in more than 50% of individuals with biallelic
      DENND5A variants were seizures (21/24), microcephaly (16/24), ventriculomegaly
      (15/24), hypertonia (14/24), cerebral hypoplasia (13/24), and hyperreflexia (13/24)"
    explanation: >-
      21/24 is 88 percent, which falls in the VERY_FREQUENT band (80-99 percent).

- category: Neurological
  name: Focal to Bilateral Tonic-Clonic Seizures
  description: >-
    The single most frequently diagnosed seizure type in the cohort, in 9 of 24 individuals.
  frequency: FREQUENT
  phenotype_term:
    preferred_term: Bilateral tonic-clonic seizure with focal onset
    term:
      id: HP:0007334
      label: Bilateral tonic-clonic seizure with focal onset
  evidence:
  - reference: PMID:39174524
    reference_title: "Loss of symmetric cell division of apical neural progenitors drives DENND5A-related developmental and epileptic encephalopathy."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Focal to bilateral tonic-clonic is the most prominent seizure type, diagnosed
      in 9 individuals"
    explanation: >-
      9/24 is 38 percent, in the FREQUENT band (30-79 percent).

- category: Neurological
  name: Epileptic Spasms
  description: >-
    Reported in 6 of 24 individuals, with generalized, focal and unknown onsets all
    represented.
  frequency: OCCASIONAL
  phenotype_term:
    preferred_term: Epileptic spasm
    term:
      id: HP:0011097
      label: Epileptic spasm
  evidence:
  - reference: PMID:39174524
    reference_title: "Loss of symmetric cell division of apical neural progenitors drives DENND5A-related developmental and epileptic encephalopathy."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Among the 6 individuals presenting with epileptic spasms, 3 had a generalized
      onset, 2 had a focal onset, and 1 had an unknown onset"
    explanation: >-
      6/24 is 25 percent, in the OCCASIONAL band (5-29 percent).

- category: Neurological
  name: Drug-Resistant Epilepsy
  description: >-
    Seizures are generally refractory. Control was achieved in only 6 of the cases, on
    varied regimens, and some agents worsened seizures.
  phenotype_term:
    preferred_term: Refractory drug response
    term:
      id: HP:0020174
      label: Refractory drug response
  evidence:
  - reference: PMID:39174524
    reference_title: "Loss of symmetric cell division of apical neural progenitors drives DENND5A-related developmental and epileptic encephalopathy."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Seizures were generally drug-resistant, but control was achieved in 6 cases
      with variable antiepileptic treatment"
    explanation: >-
      States drug resistance as the general pattern with a minority achieving control.

- category: Neurological
  name: Primary Microcephaly
  description: >-
    Present in 16 of 24 individuals and, in every case, primary rather than acquired - the
    head was already small, consistent with a defect in prenatal neurogenesis rather than
    postnatal loss. Occipitofrontal circumference percentiles varied widely across the
    cohort.
  frequency: FREQUENT
  phenotype_term:
    preferred_term: Primary microcephaly
    term:
      id: HP:0011451
      label: Primary microcephaly
  evidence:
  - reference: PMID:39174524
    reference_title: "Loss of symmetric cell division of apical neural progenitors drives DENND5A-related developmental and epileptic encephalopathy."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "All cases of microcephaly in the cohort were primary, with no cases of
      secondary microcephaly reported"
    explanation: >-
      Establishes the microcephaly as primary, which is what ties it to the prenatal
      neurogenesis defect rather than to postnatal degeneration.
  - reference: PMID:39174524
    reference_title: "Loss of symmetric cell division of apical neural progenitors drives DENND5A-related developmental and epileptic encephalopathy."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "seizures (21/24), microcephaly (16/24), ventriculomegaly (15/24), hypertonia
      (14/24), cerebral hypoplasia (13/24), and hyperreflexia (13/24)"
    explanation: >-
      16/24 is 67 percent, in the FREQUENT band (30-79 percent).

- category: Neurological
  name: Ventriculomegaly
  description: >-
    Enlarged lateral ventricles in 15 of 24 individuals, reproduced quantitatively in the
    knock-in mouse.
  frequency: FREQUENT
  phenotype_term:
    preferred_term: Ventriculomegaly
    term:
      id: HP:0002119
      label: Ventriculomegaly
  evidence:
  - reference: PMID:39174524
    reference_title: "Loss of symmetric cell division of apical neural progenitors drives DENND5A-related developmental and epileptic encephalopathy."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "microcephaly (16/24), ventriculomegaly (15/24), hypertonia (14/24), cerebral
      hypoplasia (13/24), and hyperreflexia (13/24)"
    explanation: >-
      15/24 is 63 percent, in the FREQUENT band (30-79 percent).

- category: Neurological
  name: Hypertonia
  description: >-
    Increased muscle tone in 14 of 24 individuals.
  frequency: FREQUENT
  phenotype_term:
    preferred_term: Hypertonia
    term:
      id: HP:0001276
      label: Hypertonia
  evidence:
  - reference: PMID:39174524
    reference_title: "Loss of symmetric cell division of apical neural progenitors drives DENND5A-related developmental and epileptic encephalopathy."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "ventriculomegaly (15/24), hypertonia (14/24), cerebral hypoplasia (13/24),
      and hyperreflexia (13/24)"
    explanation: >-
      14/24 is 58 percent, in the FREQUENT band (30-79 percent).

- category: Neurological
  name: Cerebral Hypoplasia
  description: >-
    Underdevelopment of cerebral structures in 13 of 24 individuals.
  frequency: FREQUENT
  phenotype_term:
    preferred_term: Cerebral hypoplasia
    term:
      id: HP:0006872
      label: Cerebral hypoplasia
  evidence:
  - reference: PMID:39174524
    reference_title: "Loss of symmetric cell division of apical neural progenitors drives DENND5A-related developmental and epileptic encephalopathy."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "hypertonia (14/24), cerebral hypoplasia (13/24), and hyperreflexia (13/24)"
    explanation: >-
      13/24 is 54 percent, in the FREQUENT band (30-79 percent).

- category: Neurological
  name: Hyperreflexia
  description: >-
    Exaggerated deep tendon reflexes in 13 of 24 individuals.
  frequency: FREQUENT
  phenotype_term:
    preferred_term: Hyperreflexia
    term:
      id: HP:0001347
      label: Hyperreflexia
  evidence:
  - reference: PMID:39174524
    reference_title: "Loss of symmetric cell division of apical neural progenitors drives DENND5A-related developmental and epileptic encephalopathy."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "cerebral hypoplasia (13/24), and hyperreflexia (13/24)"
    explanation: >-
      13/24 is 54 percent, in the FREQUENT band (30-79 percent).

- category: Neurological
  name: Absent Speech
  description: >-
    15 of 24 individuals were nonverbal; a further 7 were limited to single words and only
    2 could speak in sentences.
  frequency: FREQUENT
  phenotype_term:
    preferred_term: Absent speech
    term:
      id: HP:0001344
      label: Absent speech
  evidence:
  - reference: PMID:39174524
    reference_title: "Loss of symmetric cell division of apical neural progenitors drives DENND5A-related developmental and epileptic encephalopathy."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Of the individuals, 15/24 (63%) were nonverbal, 7/24 (29%) were limited to
      single-word speech, and 2/24 (8%) could speak in sentences"
    explanation: >-
      63 percent nonverbal falls in the FREQUENT band (30-79 percent); the figure is stated
      directly by the source.

- category: Neurological
  name: Reduced Eye Contact
  description: >-
    Eye contact was present in only 11 of 24 individuals, so 13 of 24 had it reduced or
    absent.
  frequency: FREQUENT
  phenotype_term:
    preferred_term: Reduced eye contact
    term:
      id: HP:0000817
      label: Reduced eye contact
  evidence:
  - reference: PMID:39174524
    reference_title: "Loss of symmetric cell division of apical neural progenitors drives DENND5A-related developmental and epileptic encephalopathy."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Eye contact was observed in 11 of 24 individuals (46%)"
    explanation: >-
      The complement, 13/24 or 54 percent, falls in the FREQUENT band. The band is derived
      from the stated count rather than quoted directly, which is why the derivation is
      spelled out here.

- category: Neurological
  name: Cerebral Calcification
  description: >-
    Striatal, lenticulostriate and periventricular calcifications. These were part of the
    original 2016 clinical description and are one of the features that brings congenital
    infection into the differential diagnosis.
  phenotype_term:
    preferred_term: Cerebral calcification
    term:
      id: HP:0002514
      label: Cerebral calcification
  evidence:
  - reference: PMID:27866705
    reference_title: "Epileptic Encephalopathy Caused by Mutations in the Guanine Nucleotide Exchange Factor DENND5A."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "we have identified an epileptic encephalopathy additionally featuring
      cerebral calcifications and coarse facial features"
    explanation: >-
      Names calcifications as part of the founding clinical description. No cohort-wide
      frequency is reported for calcifications, so no frequency band is asserted.

- category: Neurological
  name: Corpus Callosum Hypoplasia or Agenesis
  description: >-
    Corpus callosum volume in the cohort was normal, thin or absent, and never increased.
    The absence of thickened tracts is a discriminating detail against the LIS1
    differential.
  phenotype_term:
    preferred_term: Hypoplasia of the corpus callosum
    term:
      id: HP:0002079
      label: Hypoplasia of the corpus callosum
  evidence:
  - reference: PMID:39174524
    reference_title: "Loss of symmetric cell division of apical neural progenitors drives DENND5A-related developmental and epileptic encephalopathy."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "In contrast, corpus callosum volumes were either normal, thin, or absent with
      no cases of increased volume in our cohort"
    explanation: >-
      Records the callosal finding and its direction, which is what distinguishes it from
      the LIS1 pattern.

- category: Neurological
  name: Pachygyria
  description: >-
    Cortical malformation with an occipital predominance - a posterior gradient, but
    without the polymicrogyria seen with OCLN variants or the dysgyria of the
    tubulinopathies.
  phenotype_term:
    preferred_term: Pachygyria
    term:
      id: HP:0001302
      label: Pachygyria
  evidence:
  - reference: PMID:39174524
    reference_title: "Loss of symmetric cell division of apical neural progenitors drives DENND5A-related developmental and epileptic encephalopathy."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "cortical malformations, particularly with pachygyria involving the occipital
      lobes"
    explanation: >-
      Locates the cortical malformation and its posterior gradient.

- category: Craniofacial
  name: Coarse Facial Features
  description: >-
    Part of the founding clinical description alongside the cerebral calcifications.
  phenotype_term:
    preferred_term: Coarse facial features
    term:
      id: HP:0000280
      label: Coarse facial features
  evidence:
  - reference: PMID:27866705
    reference_title: "Epileptic Encephalopathy Caused by Mutations in the Guanine Nucleotide Exchange Factor DENND5A."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "an epileptic encephalopathy additionally featuring cerebral calcifications
      and coarse facial features"
    explanation: >-
      Names coarse facial features in the founding description.

prevalence:
- population: Worldwide
  measure_type: CASES_IN_LITERATURE
  prevalence_class: ULTRA_RARE
  notes: >-
    24 individuals from 22 families in the definitive 2024 cohort, which incorporated the
    families reported earlier. No population prevalence estimate exists.
  evidence:
  - reference: PMID:39174524
    reference_title: "Loss of symmetric cell division of apical neural progenitors drives DENND5A-related developmental and epileptic encephalopathy."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "we identified a cohort of 24 people (11F, 13M, mean age = 9.0 years, SD =
      6.0) from 22 families with biallelic DENND5A variants"
    explanation: >-
      The total reported case count as of the 2024 study.

genetic:
- name: DENND5A
  gene_term:
    preferred_term: DENND5A
    term:
      id: hgnc:19344
      label: DENND5A
  relationship_type: CAUSATIVE
  association: >-
    Biallelic loss-of-function variants in DENND5A cause DEE49. Thirty unique variants are
    reported across 22 families - 25 coding, 2 copy number and 3 splice-site - distributed
    across all folded domains. Variant class is itself a severity modifier: biallelic
    frameshift or nonsense variants produce significantly more neurological abnormality
    than biallelic missense variants.
  evidence:
  - reference: PMID:27866705
    reference_title: "Epileptic Encephalopathy Caused by Mutations in the Guanine Nucleotide Exchange Factor DENND5A."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "caused by recessive loss-of-function mutations in DENND5A"
    explanation: >-
      The gene-disease assertion.
  - reference: PMID:39174524
    reference_title: "Loss of symmetric cell division of apical neural progenitors drives DENND5A-related developmental and epileptic encephalopathy."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "found that variant type influences neurological phenotype severity, with more
      abnormalities in individuals with biallelic frameshift or nonsense variants (M = 7.6,
      SD = 2.3) compared to those with biallelic missense variants (M = 2.8, SD = 1.6, p =
      0.0004)"
    explanation: >-
      Quantifies variant class as a severity modifier, with the statistic.
  - reference: PMID:39174524
    reference_title: "Loss of symmetric cell division of apical neural progenitors drives DENND5A-related developmental and epileptic encephalopathy."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Additionally, those with biallelic missense variants in DENND5A (M = 7.4, SD =
      3.7) had significantly higher motor scores compared to those with a combination of
      missense, frameshift, nonsense, intronic, or copy number variants (M = 2.9, SD = 3.0,
      Kruskal-Wallis H = 7.02, p = 0.03"
    explanation: >-
      The parallel gradient in motor outcome across the same variant classes.
  notes: >-
    The recurrent missense variant R710H is the one place where a simple loss-of-function
    reading is insufficient. R710H sits in the DENN-RUN1 linker and is predicted to break a
    salt bridge to D598 that holds the closed conformation; experimentally it INCREASES
    binding to MUPP1 and PALS1 rather than abolishing it. The gain-of-interaction and the
    loss-of-protein findings are recorded here without being reconciled, because no source
    available to this entry does so - see the corresponding discussion.
    The deep-research report used to build this entry attributes PMID:27866705 to "Suri et
    al. 2016" and PMID:39174524 to "Rodrigues et al."; the actual first authors are Han and
    Banks respectively. The PMIDs themselves are correct and are what this entry cites.

diagnosis:
- name: Brain Magnetic Resonance Imaging
  description: >-
    Neuroimaging is how these patients reach genetic testing rather than how the diagnosis
    is made. The imaging phenotype is distinctive enough to prompt a specific search -
    occipital-predominant pachygyria with striatal and periventricular calcifications,
    ventriculomegaly, corpus callosum agenesis or hypoplasia, basal ganglia and
    diencephalic-mesencephalic junction dysplasia - but not specific enough to settle it,
    since the same constellation raises OCLN-related disease, the tubulinopathies,
    LIS1-related lissencephaly and congenital infection.
  diagnosis_term:
    preferred_term: Magnetic Resonance Imaging
    term:
      id: NCIT:C16809
      label: Magnetic Resonance Imaging
  evidence:
  - reference: PMID:39174524
    reference_title: "Loss of symmetric cell division of apical neural progenitors drives DENND5A-related developmental and epileptic encephalopathy."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "These imaging studies highlight the heterogenous neuroanatomical
      manifestations of biallelic DENND5A variants, but certain features including volume
      loss, ventriculomegaly, and hypoplasia of the corpus callosum appear more frequently"
    explanation: >-
      States both what imaging reliably shows and that it is heterogeneous - the reason it
      narrows the differential without closing it.
  notes: >-
    CT is an acceptable substitute where MRI is unavailable and was the modality in at least
    one cohort member, but it is not separately curated: NCIT's CT terms describe the
    procedure without the neuro qualifier that would make the entry more informative than
    this one.

- name: Exome or Genome Sequencing
  description: >-
    The diagnosis is molecular. There is no biochemical marker and the neuroimaging
    phenotype, while characteristic, overlaps enough with OCLN-related disease, the
    tubulinopathies, LIS1-related lissencephaly and congenital infection that imaging alone
    does not settle it.
  diagnosis_term:
    preferred_term: Whole Exome Sequencing
    term:
      id: NCIT:C101295
      label: Whole Exome Sequencing
  evidence:
  - reference: PMID:39174524
    reference_title: "Loss of symmetric cell division of apical neural progenitors drives DENND5A-related developmental and epileptic encephalopathy."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "there is a selective involvement of the cortex added to the presence of
      periventricular calcifications, a common association that brings cytomegalovirus-
      induced brain malformations into the differential but aligns with pseudo-TORCH
      syndrome diagnostic criteria in the absence of congenital infection"
    explanation: >-
      Documents the imaging differential that makes molecular confirmation necessary rather
      than confirmatory.

differential_diagnoses:
- name: Pseudo-TORCH syndrome and OCLN-related band-like calcification
  disease_term:
    preferred_term: pseudo-TORCH syndrome
    term:
      id: MONDO:0009626
      label: pseudo-TORCH syndrome
  description: >-
    The closest mechanistic mimic, and not by coincidence. OCLN encodes the tight-junction
    protein occludin, and recessive OCLN variants cause a DEE through a defect in the same
    process this disorder disrupts - neural progenitor symmetric cell division, there via
    impaired mitotic spindle formation and centrosome misalignment. The imaging converges
    too: cortical migration abnormalities plus calcifications.
  distinguishing_features:
  - >-
    Polymicrogyria is a key feature of OCLN variants and is not seen in the DENND5A cohort,
    which shows occipital pachygyria instead.
  - >-
    Severe basal ganglia dysplasia and diencephalic-mesencephalic junction dysplasia are
    reported in DENND5A and were not reported with OCLN.
  evidence:
  - reference: PMID:39174524
    reference_title: "Loss of symmetric cell division of apical neural progenitors drives DENND5A-related developmental and epileptic encephalopathy."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Cortical migration abnormalities and calcifications are observed in cases with
      recessive variants in the tight junction protein-encoding OCLN gene, but severe basal
      ganglia or diencephalic and mesencephalic dysplasias were not reported and
      polymicrogyria, a key feature of OCLN mutations, is not observed in our study"
    explanation: >-
      States both the overlap and the two features that separate them.

- name: Congenital cytomegalovirus infection
  disease_term:
    preferred_term: fetal cytomegalovirus syndrome
    term:
      id: MONDO:0017409
      label: fetal cytomegalovirus syndrome
  description: >-
    The differential a clinician actually faces first. Periventricular calcifications with
    selective cortical involvement is a classic congenital-infection pattern, and the
    DENND5A imaging phenotype reproduces it closely enough that the paper names the
    confusion explicitly.
  distinguishing_features:
  - >-
    Absence of congenital infection on serology or PCR. The same constellation then aligns
    with pseudo-TORCH diagnostic criteria - which is to say, with a genetic rather than an
    infectious cause.
  evidence:
  - reference: PMID:39174524
    reference_title: "Loss of symmetric cell division of apical neural progenitors drives DENND5A-related developmental and epileptic encephalopathy."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "there is a selective involvement of the cortex added to the presence of
      periventricular calcifications, a common association that brings cytomegalovirus-
      induced brain malformations into the differential but aligns with pseudo-TORCH
      syndrome diagnostic criteria in the absence of congenital infection"
    explanation: >-
      Names congenital CMV as the differential the imaging raises, and the finding that
      resolves it.

- name: LIS1-related lissencephaly
  description: >-
    LIS1 encodes a neuronal migration protein and produces a posterior gradient of
    lissencephaly - the same posterior-predominant direction as the DENND5A pachygyria,
    which is what makes it a live differential rather than a distant one.
  distinguishing_features:
  - >-
    Calcifications are absent in LIS1-related lissencephaly and present in DENND5A.
  - >-
    Corpus callosum size in LIS1 varies in both directions, including thicker than normal;
    in the DENND5A cohort it was normal, thin or absent with no case of increased volume.
    The directionality of the callosal finding, not merely its presence, is the
    discriminator.
  evidence:
  - reference: PMID:39174524
    reference_title: "Loss of symmetric cell division of apical neural progenitors drives DENND5A-related developmental and epileptic encephalopathy."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Variants in LIS1, encoding a protein involved in neuronal migration, results
      most frequently in a posterior gradient of lissencephaly, without calcifications, and
      variable degrees of corpus callosum size including thin, normal, and thicker than
      normal tracts"
    explanation: >-
      Gives both distinguishing features - the absent calcifications and the bidirectional
      callosal variation.
  - reference: PMID:39174524
    reference_title: "Loss of symmetric cell division of apical neural progenitors drives DENND5A-related developmental and epileptic encephalopathy."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "In contrast, corpus callosum volumes were either normal, thin, or absent with
      no cases of increased volume in our cohort"
    explanation: >-
      The DENND5A side of the callosal contrast.
  notes: >-
    No disease_term is bound. MONDO has no single term for LIS1-related lissencephaly as a
    class - the relevant concepts are gene- and syndrome-specific (Miller-Dieker, isolated
    lissencephaly sequence) and the source speaks of "variants in LIS1" generally, so
    binding any one of them would narrow the claim beyond what is written.

- name: Tubulinopathies
  description: >-
    Tubulin gene variants produce overlapping cortical malformation phenotypes and belong in
    the same imaging differential.
  distinguishing_features:
  - >-
    The tubulinopathies show a classic dysgyria pattern that the DENND5A cohort lacks.
  - >-
    The tubulinopathies are not associated with calcifications, which are present in
    DENND5A.
  evidence:
  - reference: PMID:39174524
    reference_title: "Loss of symmetric cell division of apical neural progenitors drives DENND5A-related developmental and epileptic encephalopathy."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Variants in tubulin genes also result in overlapping phenotypes47, but our
      cases lack the classic dysgyria pattern and instead are observed in the context of
      occipital pachygyria and differ in that our cases are associated with calcifications"
    explanation: >-
      States the overlap and both discriminating features.
  notes: >-
    No disease_term is bound: "tubulinopathies" names a gene-family grouping (TUBA1A, TUBB2B,
    TUBB3 and others) rather than one MONDO concept, and the source refers to the class.

treatments:
- name: Antiseizure Medication
  description: >-
    Management is symptomatic. No agent has disease-specific efficacy evidence, seizures
    are generally drug-resistant, and the cohort record includes agents that worsened
    seizures as well as agents that helped - phenytoin and lamotrigine each worsened
    seizures in one individual. Levetiracetam and sodium valproate were the most commonly
    reported agents achieving control.
  therapeutic_modality: SMALL_MOLECULE
  treatment_term:
    preferred_term: Pharmacotherapy
    term:
      id: NCIT:C15986
      label: Pharmacotherapy
    therapeutic_agent:
    - preferred_term: levetiracetam
      term:
        id: CHEBI:6437
        label: levetiracetam
    - preferred_term: valproic acid
      term:
        id: CHEBI:39867
        label: valproic acid
  evidence:
  - reference: PMID:39174524
    reference_title: "Loss of symmetric cell division of apical neural progenitors drives DENND5A-related developmental and epileptic encephalopathy."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Seizures were generally drug-resistant, but control was achieved in 6 cases
      with variable antiepileptic treatment. Anti-seizure medications variably helped, did
      not affect, or worsened seizures"
    explanation: >-
      Curated PARTIAL: it records a mixed and often unsuccessful response, not an effective
      treatment. The explicit inclusion of worsening is why this cannot be read as support
      for antiseizure medication as such.
  notes: >-
    The mechanism gives no obvious therapeutic handle. The rate-limiting defect - spindle
    misorientation in apical progenitors - occurs during prenatal neurogenesis and is
    complete before the disorder presents, so a treatment aimed at the mechanism would have
    to act on a window that has closed by the time of diagnosis. This is a structural
    limitation of the disorder, not a gap in the drug literature.

- name: Genetic Counseling
  description: >-
    Autosomal recessive with a 25 percent recurrence risk per pregnancy for carrier
    couples. Consanguinity was a feature of the founding families, which is the standard
    context for identifying biallelic rare-variant disease.
  therapeutic_modality: BEHAVIORAL
  treatment_term:
    preferred_term: Genetic Counseling
    term:
      id: NCIT:C15240
      label: Genetic Counseling
  evidence:
  - reference: PMID:39174524
    reference_title: "Loss of symmetric cell division of apical neural progenitors drives DENND5A-related developmental and epileptic encephalopathy."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "For families in which one parent is aware they are a carrier of a pathogenic
      DENND5A variant, genetic counselors can recommend the other parent undergo genetic
      testing. When both parents are carriers, in vitro fertilization with preimplantation
      genetic diagnosis can be offered"
    explanation: >-
      Names genetic counselors, carrier testing of the second parent, and IVF with
      preimplantation genetic diagnosis - the reproductive options this treatment entry
      asserts. This replaces an earlier quote that was the paper's generic closing sentence
      about being clinically informative, which did not state any of it.
  - reference: PMID:39174524
    reference_title: "Loss of symmetric cell division of apical neural progenitors drives DENND5A-related developmental and epileptic encephalopathy."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "the presence of DENND5A VUSs does not necessarily equate to a devastating
      prognosis; 13% (3 cases) of our small cohort did not meet criteria for DEE or
      experience seizures at the time of data collection"
    explanation: >-
      Curated PARTIAL because it qualifies rather than supports: the counseling message is
      not uniformly severe. This is the same 3 of 24 recorded on the seizure endpoint node,
      and it is the counseling-relevant reading of that number.

animal_models:
- name: DENND5A knock-in mouse
  species: Mouse
  genotype: homozygous DENND5A knock-in (no full-length protein expressed)
  publication: PMID:39174524
  description: >-
    A knock-in line in which full-length DENND5A protein is not expressed. Used for
    structural neuroimaging, adult subventricular zone histology and chemically provoked
    seizure susceptibility.
  modeled_mechanisms:
  - target: Compensatory Ventriculomegaly
    relationship: RECAPITULATES
    fidelity: HIGH
    limitations: >-
      Ventricular volume was measured in adults; the model does not report the
      developmental time course by which the enlargement arises, so it corroborates the
      endpoint rather than the compensatory interpretation placed on it.
    description: >-
      In vivo 7T MRI reproduces the human ventriculomegaly.
    readouts:
    - name: Lateral ventricle volume
      target: Compensatory Ventriculomegaly
      direction: INCREASED
      interpretation: >-
        Significantly enlarged lateral ventricles in knock-in mice.
      evidence:
      - reference: PMID:39174524
        reference_title: "Loss of symmetric cell division of apical neural progenitors drives DENND5A-related developmental and epileptic encephalopathy."
        supports: SUPPORT
        evidence_source: MODEL_ORGANISM
        snippet: "DENND5A KI mice have significantly enlarged lateral ventricles (MWT = 4.8
          mm3, MKI = 6.6 mm3, SDWT = 1.3, SDKI = 2.4, two-tailed Mann-Whitney U, Z =
          −2.117, p = 0.034)"
        explanation: >-
          The quantitative volumetric measurement.
    evidence:
    - reference: PMID:39174524
      reference_title: "Loss of symmetric cell division of apical neural progenitors drives DENND5A-related developmental and epileptic encephalopathy."
      supports: SUPPORT
      evidence_source: MODEL_ORGANISM
      snippet: "In vivo 7T MRI scans revealed that DENND5A KI mice have significantly
        enlarged lateral ventricles"
      explanation: >-
        Supports treating the mouse as informative for the human ventriculomegaly.
  - target: Premature Neuronal Differentiation and Cell Cycle Exit
    relationship: RECAPITULATES
    fidelity: MODERATE
    limitations: >-
      Measured in the adult subventricular zone, not the embryonic ventricular zone where
      the disorder's neurogenesis defect is proposed to occur. Adult SVZ neurogenesis is a
      different process from cortical neurogenesis, so this is a corroborating observation
      in an analogous niche rather than a direct test of the developmental claim.
    description: >-
      A higher proportion of post-mitotic neurons in the adult neurogenic niche.
    readouts:
    - name: NeuN-positive post-mitotic neurons in the subventricular zone
      target: Premature Neuronal Differentiation and Cell Cycle Exit
      direction: INCREASED
      interpretation: >-
        Knock-in mice have proportionally more post-mitotic neurons, consistent with
        progenitors exiting the cycle.
      evidence:
      - reference: PMID:39174524
        reference_title: "Loss of symmetric cell division of apical neural progenitors drives DENND5A-related developmental and epileptic encephalopathy."
        supports: SUPPORT
        evidence_source: MODEL_ORGANISM
        snippet: "KI mice have a significantly higher percentage of post-mitotic neurons
          expressing NeuN compared to WT mice"
        explanation: >-
          The histological measurement behind this readout.
    - name: GFAP-positive stem-like cells in the subventricular zone
      target: Premature Neuronal Differentiation and Cell Cycle Exit
      direction: UNCHANGED
      interpretation: >-
        A real negative result, retained rather than dropped. The expected reciprocal fall
        in the GFAP-positive stem-like population was present in the mean but did not reach
        significance, so the stem-cell-depletion half of the model is not demonstrated in
        this assay even though the neuronal half is.
      evidence:
      - reference: PMID:39174524
        reference_title: "Loss of symmetric cell division of apical neural progenitors drives DENND5A-related developmental and epileptic encephalopathy."
        supports: SUPPORT
        evidence_source: MODEL_ORGANISM
        snippet: "While there is also a reduction in the mean proportion of GFAP-positive
          cells in the SVZ of the KI mice, it did not reach significance"
        explanation: >-
          The non-significant measurement, stated directly by the source.
    evidence:
    - reference: PMID:39174524
      reference_title: "Loss of symmetric cell division of apical neural progenitors drives DENND5A-related developmental and epileptic encephalopathy."
      supports: SUPPORT
      evidence_source: MODEL_ORGANISM
      snippet: "we used our DENND5A KI mice to examine the adult subventricular zone (SVZ),
        a region that normally retains GFAP-positive RG-like neural stem cells"
      explanation: >-
        Establishes what niche was examined and why it was chosen as an analogue.
  - target: Seizure Generation and Developmental and Epileptic Encephalopathy
    relationship: PARTIALLY_RECAPITULATES
    fidelity: MODERATE
    limitations: >-
      The mice do not have spontaneous seizures. What is measured is a lowered threshold to
      a chemoconvulsant, 4-aminopyridine, which is a susceptibility phenotype and not
      epilepsy. The human disorder is defined by recurrent unprovoked seizures, so this is
      the weakest correspondence in the model.
    description: >-
      Increased chemoconvulsant seizure susceptibility without spontaneous seizures.
    readouts:
    - name: Latency to seizure after 4-aminopyridine
      target: Seizure Generation and Developmental and Epileptic Encephalopathy
      direction: DECREASED
      interpretation: >-
        Knock-in mice seize sooner after 4-AP than wild-type, indicating a lowered seizure
        threshold.
      evidence:
      - reference: PMID:39174524
        reference_title: "Loss of symmetric cell division of apical neural progenitors drives DENND5A-related developmental and epileptic encephalopathy."
        supports: SUPPORT
        evidence_source: MODEL_ORGANISM
        snippet: "they show increased seizure susceptibility compared to WT when
          administered the potassium channel blocker 4-aminopyridine (MWT = 23.60, MKI =
          11.67, SDWT = 2.97, SDKI = 7.20, two-tailed t(9) = 3.445, p = 0.007"
        explanation: >-
          The latency measurement behind this readout.
    - name: Spontaneous seizures
      target: Seizure Generation and Developmental and Epileptic Encephalopathy
      direction: UNCHANGED
      interpretation: >-
        A real negative result. No spontaneous seizures were observed, which is why the
        relationship is PARTIALLY_RECAPITULATES rather than RECAPITULATES.
      evidence:
      - reference: PMID:39174524
        reference_title: "Loss of symmetric cell division of apical neural progenitors drives DENND5A-related developmental and epileptic encephalopathy."
        supports: SUPPORT
        evidence_source: MODEL_ORGANISM
        snippet: "while spontaneous seizures were not observed in the KI mice, they show
          increased seizure susceptibility compared to WT"
        explanation: >-
          The source's own statement that the spontaneous phenotype is absent.
    evidence:
    - reference: PMID:39174524
      reference_title: "Loss of symmetric cell division of apical neural progenitors drives DENND5A-related developmental and epileptic encephalopathy."
      supports: SUPPORT
      evidence_source: MODEL_ORGANISM
      snippet: "Finally, while spontaneous seizures were not observed in the KI mice, they
        show increased seizure susceptibility compared to WT"
      explanation: >-
        Curated PARTIAL because the model captures threshold, not the recurrent unprovoked
        seizures that define the human disorder.
  - target: Reduced Brain Volume and Cortical Malformation
    relationship: FAILS_TO_RECAPITULATE
    fidelity: LOW
    limitations: >-
      Relative brain size was lower in mean and median but the difference did not reach
      statistical significance, with high variability. The authors note the same
      variability in human occipitofrontal circumference, so the failure may reflect the
      trait's variance rather than an absent phenotype - but as measured, the mouse does not
      demonstrate reduced brain size, and this entry does not report it as though it did.
    description: >-
      The microcephaly phenotype is not statistically reproduced in the mouse.
    readouts:
    - name: Relative brain size
      target: Reduced Brain Volume and Cortical Malformation
      direction: UNCHANGED
      interpretation: >-
        Lower in mean and median but not significantly so.
      evidence:
      - reference: PMID:39174524
        reference_title: "Loss of symmetric cell division of apical neural progenitors drives DENND5A-related developmental and epileptic encephalopathy."
        supports: REFUTE
        evidence_source: MODEL_ORGANISM
        snippet: "KI mice also have a lower mean and median relative brain sizes, but like
          the human cohort in which occipitofrontal circumference percentiles varied
          considerably, a high degree of variability was observed in the mice and the
          difference did not reach statistical significance"
        explanation: >-
          Curated REFUTE for this specific readout: the measurement does not support a
          reduced brain size in this model, and the source says so directly.
    evidence:
    - reference: PMID:39174524
      reference_title: "Loss of symmetric cell division of apical neural progenitors drives DENND5A-related developmental and epileptic encephalopathy."
      supports: REFUTE
      evidence_source: MODEL_ORGANISM
      snippet: "a high degree of variability was observed in the mice and the difference did
        not reach statistical significance"
      explanation: >-
        The negative result that requires this link to be curated as
        FAILS_TO_RECAPITULATE.

- name: dennd5a F0 CRISPR knockout zebrafish
  species: Zebrafish
  genotype: biallelic dennd5a CRISPR/Cas9 F0 knockout (crispant)
  publication: PMID:39174524
  description: >-
    F0 crispants carrying biallelic dennd5a mutations, phenotyped morphologically at 5 days
    post fertilization. The value of this model is that it reproduces the two structural
    findings - small head, large ventricle - in a second species and at a whole-organism
    developmental scale.
  modeled_mechanisms:
  - target: Reduced Brain Volume and Cortical Malformation
    relationship: RECAPITULATES
    fidelity: MODERATE
    limitations: >-
      F0 crispants are genetic mosaics, so the penetrance of the biallelic state varies
      between and within animals. Head size in a larval zebrafish is a coarse proxy for
      human microcephaly, and the zebrafish brain has no cortex, so the cortical
      malformation component of this node cannot be modeled here at all.
    description: >-
      Reduced head size and enlarged ventricle in the knockout larvae.
    readouts:
    - name: Head size
      target: Reduced Brain Volume and Cortical Malformation
      direction: DECREASED
      interpretation: >-
        Reduced head size in F0 knockouts, the cross-species correlate of microcephaly.
      evidence:
      - reference: PMID:39174524
        reference_title: "Loss of symmetric cell division of apical neural progenitors drives DENND5A-related developmental and epileptic encephalopathy."
        supports: SUPPORT
        evidence_source: MODEL_ORGANISM
        snippet: "F0 KOs show structural and behavioral perturbations consistent with
          DENND5A-related DEE including reduced head size and increased ventricle size"
        explanation: >-
          The morphological measurements behind this readout.
    evidence:
    - reference: PMID:39174524
      reference_title: "Loss of symmetric cell division of apical neural progenitors drives DENND5A-related developmental and epileptic encephalopathy."
      supports: SUPPORT
      evidence_source: MODEL_ORGANISM
      snippet: "Biallelic mutations in dennd5a were introduced into zebrafish larvae using
        CRISPR/Cas9 (F0 KOs)"
      explanation: >-
        Establishes the model as a biallelic knockout matching the human genotype.

experimental_models:
- name: DENND5A knockout human iPSC-derived neural rosettes
  experimental_model_type: IPSC_DERIVED_MODEL
  description: >-
    Neural rosettes formed from wild-type and CRISPR/Cas9 DENND5A knockout human iPSCs. A
    rosette is a polarized in vitro model of early neural development with a central
    F-actin-rich lumen standing in for the ventricular surface, which is what makes the
    mitotic spindle angle measurable at all. This is the system that produced the
    disorder's central quantitative finding.
  publication: PMID:39174524
  modeled_mechanisms:
  - target: Mitotic Spindle Misorientation in Apical Neural Progenitors
    relationship: RECAPITULATES
    fidelity: HIGH
    limitations: >-
      Human but not patient-derived: the knockout is engineered, so the model tests the
      consequence of absent DENND5A rather than of any particular patient allele. The
      spindle-angle measurement also required excluding cells whose chromatin was
      abnormally condensed - a class over-represented in the knockouts - so the reported
      angle distribution is drawn from the subset of knockout divisions that looked
      normal enough to measure.
    description: >-
      Direct quantification of mitotic spindle angle relative to the apical surface.
    readouts:
    - name: Mitotic spindle angle relative to the apical surface
      target: Mitotic Spindle Misorientation in Apical Neural Progenitors
      direction: DECREASED
      interpretation: >-
        Knockout progenitors divide at a much shallower angle to the apical surface than
        wild-type, and most fall below the 45 degree line that separates symmetric from
        oblique division.
      evidence:
      - reference: PMID:39174524
        reference_title: "Loss of symmetric cell division of apical neural progenitors drives DENND5A-related developmental and epileptic encephalopathy."
        supports: SUPPORT
        evidence_source: IN_VITRO
        snippet: "the spindle angle among cells dividing within WT (M = 57.1°, Mdn = 65.4°,
          SD = 25.9) and KO (M = 26.0°, Mdn = 20.1°, SD = 19.0) rosettes differed
          significantly"
        explanation: >-
          The quantitative angle measurement.
    - name: Apical localization of PALS1
      target: Mitotic Spindle Misorientation in Apical Neural Progenitors
      direction: UNCHANGED
      interpretation: >-
        A real negative result that constrains the mechanism. PALS1 still reaches the apical
        membrane without DENND5A, so DENND5A is not required to traffic the polarity complex
        there - which is why the edge from the interaction node to this one is curated with
        unknown intermediates rather than as a direct trafficking failure.
      evidence:
      - reference: PMID:39174524
        reference_title: "Loss of symmetric cell division of apical neural progenitors drives DENND5A-related developmental and epileptic encephalopathy."
        supports: SUPPORT
        evidence_source: IN_VITRO
        snippet: "PALS1 localized apically in both WT and KO rosettes (Supplementary Fig.
          5f), suggesting DENND5A is not involved in trafficking MUPP1/PALS1 to the apical
          membrane"
        explanation: >-
          The negative localization result, stated directly by the source.
    evidence:
    - reference: PMID:39174524
      reference_title: "Loss of symmetric cell division of apical neural progenitors drives DENND5A-related developmental and epileptic encephalopathy."
      supports: SUPPORT
      evidence_source: IN_VITRO
      snippet: "We performed a neural rosette formation assay, a polarized in vitro model of
        early neural development, to examine for potential alterations in the symmetry of
        cell division following loss of DENND5A"
      explanation: >-
        Establishes the model and what it was used to measure.

- name: DENND5A knockout human iPSC-derived neural progenitor cells
  experimental_model_type: IPSC_DERIVED_MODEL
  description: >-
    Neural progenitors differentiated from wild-type and DENND5A knockout human iPSCs,
    validated as SOX1, SOX2 and Nestin positive. Used for proliferation counts and for the
    premature differentiation assay.
  publication: PMID:39174524
  modeled_mechanisms:
  - target: Neural Progenitor Pool Depletion
    relationship: RECAPITULATES
    fidelity: HIGH
    limitations: >-
      Part of the day-one difference is attributed by the authors to increased apoptosis in
      knockout cells after plating rather than to slower division, so the proliferation
      deficit and a survival deficit are not fully separated in this assay.
    description: >-
      Knockout progenitors fail to expand.
    readouts:
    - name: Neural progenitor cell number over 72 hours
      target: Neural Progenitor Pool Depletion
      direction: DECREASED
      interpretation: >-
        Wild-type progenitors expand while knockouts stay nearly flat, with the gap widening
        from 48 to 72 hours.
      evidence:
      - reference: PMID:39174524
        reference_title: "Loss of symmetric cell division of apical neural progenitors drives DENND5A-related developmental and epileptic encephalopathy."
        supports: SUPPORT
        evidence_source: IN_VITRO
        snippet: "We observed that DENND5A KO NPCs grow slower than WT"
        explanation: >-
          The proliferation measurement behind this readout.
    evidence:
    - reference: PMID:39174524
      reference_title: "Loss of symmetric cell division of apical neural progenitors drives DENND5A-related developmental and epileptic encephalopathy."
      supports: SUPPORT
      evidence_source: IN_VITRO
      snippet: "NPCs express SOX1, SOX2, and Nestin, affirming their NPC identity"
      explanation: >-
        Establishes the identity of the cells used, which is what makes the proliferation
        claim about progenitors rather than about mixed culture.
  - target: Premature Neuronal Differentiation and Cell Cycle Exit
    relationship: RECAPITULATES
    fidelity: HIGH
    limitations: >-
      The assay reports the proportion of cells with neuronal morphology and beta-III
      tubulin staining after one day, not a full differentiation trajectory or a subtype
      assignment, so it establishes that the cells commit early without saying what they
      commit to.
    description: >-
      Knockout progenitors develop neuronal processes under conditions meant to keep them
      undifferentiated.
    readouts:
    - name: Proportion of beta-III tubulin-positive cells in maintenance medium
      target: Premature Neuronal Differentiation and Cell Cycle Exit
      direction: INCREASED
      interpretation: >-
        47.29 percent of knockout cells against 10.67 percent of wild-type, one day after
        passage into progenitor maintenance medium.
      evidence:
      - reference: PMID:39174524
        reference_title: "Loss of symmetric cell division of apical neural progenitors drives DENND5A-related developmental and epileptic encephalopathy."
        supports: SUPPORT
        evidence_source: IN_VITRO
        snippet: "Our results suggest that DENND5A expression promotes stemness and its loss
          drives cell cycle exit and premature differentiation into neuronal phenotypes"
        explanation: >-
          The authors' statement of what the differentiation measurements show.
    evidence:
    - reference: PMID:39174524
      reference_title: "Loss of symmetric cell division of apical neural progenitors drives DENND5A-related developmental and epileptic encephalopathy."
      supports: SUPPORT
      evidence_source: IN_VITRO
      snippet: "Human induced pluripotent stem cells lacking DENND5A fail to undergo
        symmetric cell division with an inherent propensity to differentiate into neurons"
      explanation: >-
        Supports treating the knockout iPSC system as informative for the differentiation
        node.

discussions:

- discussion_id: controversy_r710h_gain_of_interaction_versus_loss_of_function
  kind: CONTROVERSY
  status: OPEN
  attaches_to:
  - pathophysiology#Reduced DENND5A Protein
  - pathophysiology#Loss of DENND5A-MUPP1/PALS1 Association at the Apical Membrane
  prompt: >-
    If the disorder is caused by loss of DENND5A function, how does a recurrent variant
    that INCREASES binding to the polarity complex cause it?
  rationale: >-
    The two findings sit in direct tension and the entry does not smooth them. Every
    patient-derived cell line shows reduced DENND5A protein, and the population genetics
    support a recessive loss-of-function model. Yet R710H, a recurrent cohort variant, lies
    in the DENN-RUN1 linker where it is predicted to break a salt bridge holding the closed
    conformation, and introducing it experimentally increases binding to MUPP1 and PALS1.
    A protein locked open would engage the polarity complex more, not less. Three readings
    are available and none is excluded. The variant may be destabilizing in cells, so that
    reduced abundance overrides increased per-molecule affinity - the R710H individual in
    the cohort is compound heterozygous, which would matter here. Or the closed
    conformation may be functionally required - if DENND5A must cycle between a Rab-binding
    RUN1-exposed state and a polarity-binding open state, then constitutive opening is a
    loss of function even though it looks like a gain of binding. Or the polarity
    interaction may not be the arm through which R710H acts at all. Which reading is right
    determines whether R710H should be curated as a distinct mechanistic class within DEE49.
  proposed_experiments:
  - experiment_id: exp_r710h_abundance_and_spindle_angle
    name: R710H knock-in iPSC rosettes with matched abundance measurement
    description: >-
      Introduce R710H as a knock-in into wild-type human iPSCs and measure both DENND5A
      protein abundance and mitotic spindle angle in the resulting rosettes, against
      wild-type and full knockout. If R710H reduces abundance and misorients spindles, it is
      a loss-of-function allele whose binding gain is irrelevant in cells. If abundance is
      preserved and spindles are still misoriented, the closed conformation is functionally
      required and constitutive opening is itself the lesion.

- discussion_id: gap_route_from_polarity_complex_to_spindle_angle
  kind: KNOWLEDGE_GAP
  status: OPEN
  attaches_to:
  - pathophysiology#Loss of DENND5A-MUPP1/PALS1 Association at the Apical Membrane
  - pathophysiology#Mitotic Spindle Misorientation in Apical Neural Progenitors
  prompt: >-
    By what molecular route does losing the DENND5A-MUPP1/PALS1 interaction change the
    orientation of the mitotic spindle?
  rationale: >-
    This is the entry's central unexplained step, and the obvious explanation has been
    tested and excluded. If DENND5A were required to deliver the polarity proteins to the
    apical membrane, their mislocalization would explain the spindle defect - but PALS1
    localizes apically in knockout rosettes just as it does in wild-type, and the authors
    state directly that DENND5A is not involved in that trafficking. Something else
    therefore connects the interaction to spindle positioning: an effect on the astral
    microtubule capture machinery, on centrosome anchoring, on the local apical actin
    cortex, or an entirely separate DENND5A function. Without this step the disease model
    holds together descriptively but not mechanistically, and the edge is curated
    INDIRECT_UNKNOWN_INTERMEDIATES for exactly that reason.
  proposed_experiments:
  - experiment_id: exp_spindle_anchoring_machinery_in_dennd5a_ko
    name: Astral microtubule and cortical anchoring machinery in DENND5A knockout rosettes
    description: >-
      Image the LGN-NuMA-dynein cortical anchoring complex and astral microtubule contacts
      at the apical cortex of dividing wild-type and DENND5A knockout rosette progenitors,
      and test whether DENND5A or MUPP1/PALS1 co-localizes with or is required for that
      complex. A defect in cortical anchoring would supply the missing step; its absence
      would redirect the search toward centrosome positioning.

- discussion_id: gap_evidence_for_the_seizure_step
  kind: KNOWLEDGE_GAP
  status: OPEN
  attaches_to:
  - pathophysiology#Aberrant Positioning and Connectivity of Prematurely Born Neurons
  - pathophysiology#Seizure Generation and Developmental and Epileptic Encephalopathy
  prompt: >-
    What actually makes DENND5A-deficient brain seize?
  rationale: >-
    The disorder is classified as a developmental and epileptic encephalopathy, and the
    developmental half is well evidenced down to quantitative spindle angles. The epileptic
    half is not. The proposed route - prematurely born neurons sitting in the wrong place
    and forming aberrant synaptic contacts - appears in the authors' disease model and is
    curated PARTIAL here because no measurement supports it: no source available to this
    entry reports excitation-inhibition balance, network synchrony, intrinsic excitability
    or synaptic physiology in DENND5A-deficient neurons. The mouse contributes threshold
    data only, and no spontaneous seizures. This is why this entry conforms to the epilepsy
    module at the clinical Recurrent Unprovoked Seizures endpoint rather than at the
    excitation-inhibition or hyperexcitability nodes: attaching upstream would let the
    module supply a mechanistic claim the evidence does not make. The authors themselves
    note that identifying whether excitatory or inhibitory neurons are disproportionately
    affected would help clinicians choose an antiseizure medication, which makes this gap
    clinically live rather than merely descriptive.
  proposed_experiments:
  - experiment_id: exp_excitatory_inhibitory_balance_in_dennd5a_deficient_cortex
    name: Excitatory and inhibitory neuron census and network physiology in DENND5A knockout
    description: >-
      Quantify excitatory and inhibitory neuron subpopulations across cortical layers in
      DENND5A knock-in mouse cortex at several developmental timepoints, and record network
      activity from DENND5A knockout human iPSC-derived neuronal cultures on multielectrode
      arrays. This tests whether the premature differentiation is subtype-biased and whether
      the resulting network is intrinsically hyperexcitable, which would convert the
      entry's inferential seizure step into a measured one.

- discussion_id: gap_which_progenitor_stage_is_primarily_affected
  kind: KNOWLEDGE_GAP
  status: OPEN
  attaches_to:
  - pathophysiology#Mitotic Spindle Misorientation in Apical Neural Progenitors
  prompt: >-
    Is the defect primarily in neuroepithelial cells or in apical radial glia?
  rationale: >-
    The two progenitor stages differ in junctional composition - neuroepithelial cells have
    tight junctions, radial glia rely on adherens junctions - and MUPP1 is reported to
    preferentially stabilize adherens junctions over tight junctions. The authors take that
    asymmetry to predict a radial-glia-specific defect, but the prediction has not been
    tested: the rosette assay does not resolve the two stages, and the mouse data come from
    the adult subventricular zone rather than the embryonic ventricular zone. Which stage is
    affected sets the developmental window and hence what a hypothetical intervention would
    have to reach.
  proposed_experiments:
  - experiment_id: exp_stage_resolved_spindle_angles_in_vivo
    name: Stage-resolved spindle angle measurement in the embryonic mouse ventricular zone
    description: >-
      Measure mitotic spindle angles of dividing apical progenitors in the DENND5A knock-in
      mouse ventricular zone across the neuroepithelial-to-radial-glia transition, with
      stage markers, and quantify progenitor and post-mitotic proportions at each timepoint.
      This is the experiment the authors themselves propose, and it would establish both the
      affected stage and whether the in vivo spindle defect matches the rosette measurement.

- discussion_id: mismatch_adult_svz_as_proxy_for_embryonic_neurogenesis
  kind: HUMAN_MODEL_MISMATCH
  status: OPEN
  attaches_to:
  - pathophysiology#Premature Neuronal Differentiation and Cell Cycle Exit
  - pathophysiology#Shortened Period of Neurogenesis
  prompt: >-
    Does increased neuronal differentiation in the adult mouse subventricular zone speak to
    a defect in human embryonic cortical neurogenesis?
  rationale: >-
    The in vivo evidence for premature differentiation comes from the adult subventricular
    zone, while the disease model is about embryonic cortical neurogenesis. These are
    different niches with different progenitors, different output lineages and different
    regulatory logic; adult SVZ neurogenesis produces olfactory bulb interneurons in mouse
    and is of contested extent in adult humans at all. The authors chose the niche because
    it retains GFAP-positive radial-glia-like stem cells, which is a reasonable analogy, but
    an analogy is what it is. Compounding this, the mouse fails to reproduce the
    microcephaly that the embryonic defect is supposed to cause - relative brain size was
    lower but not significantly so. The human iPSC rosette and progenitor data carry the
    developmental claim; the mouse SVZ result corroborates it in an adjacent system and
    should not be read as confirming it in the relevant one.
  proposed_experiments:
  - experiment_id: exp_embryonic_vz_differentiation_timecourse
    name: Embryonic ventricular zone progenitor and neuron census across neurogenesis
    description: >-
      Quantify progenitor and post-mitotic neuron proportions in the DENND5A knock-in mouse
      embryonic ventricular and subventricular zones across the full neurogenic period, and
      compare the trajectory to wild-type. If the premature-differentiation shift is present
      embryonically and cortically, the adult SVZ result becomes corroboration rather than
      the primary in vivo evidence; if it is absent, the mouse does not model the human
      developmental mechanism and the microcephaly failure is explained.

notes: >-
  Scope: this entry curates DEE49, the autosomal recessive disorder caused by biallelic
  DENND5A variants. Heterozygous DENND5A loss-of-function variants are separately reported
  to predispose to familial cutaneous melanoma through an SNX1-related trafficking deficit;
  that is a different disorder with a different mode of inheritance and is not modeled here.
  Evidence base. Two primary sources: the 2016 founding report (PMID:27866705, abstract
  only in the reference cache) and the 2024 Nature Communications cohort and mechanism study
  (PMID:39174524, full text). All snippets are quoted from those cached records. The
  quantitative figures in the pathophysiology descriptions - spindle angles, cell counts,
  differentiation percentages - come from the 2024 full text; where a figure appears in a
  description rather than in a snippet it is because the source sentence carrying it also
  carries statistical notation that does not quote cleanly.
  A third reference proposed by the deep-research report, PMID:27431290 (Anazi et al. 2017),
  was fetched and then not used: it is a broad intellectual-disability genomics paper whose
  retrievable abstract does not mention DENND5A, so it cannot support any DENND5A-specific
  claim quoted from it. The report also cites PMID:38352438, the medRxiv preprint of the
  same 2024 study; the published version is cited instead.
  Hypotonia is deliberately not curated. It appears in the research report from the OMIM
  clinical synopsis rather than from either primary source, and neither cached paper states
  it in a form that could be quoted. The cohort's own motor findings - 8 of 24 walking
  independently, 11 of 24 able to grasp - are curated instead, since those are counted in
  the source. If a future curator adds hypotonia it should come with a primary citation, not
  from the synopsis.
  Ontology terms proposed by the deep-research report and rejected after checking against
  OAK: GO:0051654 was proposed for spindle localization but is "establishment of
  mitochondrion localization"; CL:0002608 was proposed for radial glial cell but is
  "hippocampal neuron"; CL:0000060 was proposed for neural progenitor cell but is
  "odontoblast". The correct terms used here are GO:0000132, CL:0000681 and CL:0011020.
  The Crumbs complex is left unbound: GO:0035003 subapical complex is defined for
  invertebrate epithelia and there is no vertebrate Crumbs complex term, so the protein
  complex carries a free-text preferred_term only.
📚

References & Deep Research

Deep Research

1
Claude Code
DENND5A-Related Developmental and Epileptic Encephalopathy: Comprehensive Research Report
claude-haiku-4-5-20251001, claude-sonnet-5 22 citations 2026-08-20T12:17:59.198528

DENND5A-Related Developmental and Epileptic Encephalopathy: Comprehensive Research Report

1. Disease Information

Overview. DENND5A-related developmental and epileptic encephalopathy (also designated Developmental and Epileptic Encephalopathy 49, DEE49) is a severe, autosomal recessive neurodevelopmental disorder caused by biallelic loss-of-function (or partial loss-of-function) variants in DENND5A. It belongs to the broader clinical/genetic category of "epileptic encephalopathies" — catastrophic infantile-onset epilepsies with refractory seizures and cognitive arrest that are usually attributable to abnormal brain development rather than solely to the seizures themselves. The original description states: "Epileptic encephalopathies are a catastrophic group of epilepsies characterized by refractory seizures and cognitive arrest, often resulting from abnormal brain development. Here, we have identified an epileptic encephalopathy additionally featuring cerebral calcifications and coarse facial features caused by recessive loss-of-function mutations in DENND5A" (Suri et al., 2016, PMID: 27866705).

Key identifiers: - OMIM disease entry: #617281 — Developmental and Epileptic Encephalopathy 49 (DEE49) - OMIM gene entry: 617278 — DENN Domain-Containing Protein 5A (DENND5A) - HGNC: HGNC:19344 - NCBI Gene ID: 23258 - Cytogenetic location: 11p15.4 (chromosome 11) - Orphanet: DENND5A is included on the Orphanet "Molecular diagnosis of Epileptic Encephalopathy" gene panel (EPI02v17.1) and the "Molecular diagnosis of Fetal Akinesia" gene panel; a disease-specific ORPHA number search returned an unreliable/unconfirmed value in secondary sources during this research (candidate ORPHA:1934 could not be independently verified against Orphanet's own disorder pages and should be confirmed directly at orpha.net before use). - MONDO: Not confirmed via direct Mondo lookup during this research; should be cross-referenced against the OMIM #617281 xref. - NIH Genetic Testing Registry (GTR): condition C4310635 ("Developmental and epileptic encephalopathy, 49") - Related umbrella:* ILAE Developmental and Epileptic Encephalopathy (DEE) nosology

Synonyms/alternative names: - Developmental and Epileptic Encephalopathy 49 (DEE49) - Epileptic Encephalopathy, Early Infantile, 49 (EIEE49) — the pre-2020 ILAE nomenclature used in earlier OMIM/literature entries (e.g., Anazi et al. 2017 refers to "EIEE49") - DENND5A deficiency

Evidence basis. The disease is characterized almost entirely from aggregated, disease-level resources built from case series/cohort studies (not large-scale EHR data): the founding 2016 report of 2 families (4 affected individuals) (PMID:27866705), a 2017 exome-sequencing cohort report identifying 2 additional patients (Anazi et al., PMID:27431290), and the definitive natural-history/mechanism cohort study that expanded the total reported cohort to 23–24 individuals from 21–22 families with 30 unique variants (Rodrigues et al., Nature Communications 2024, PMID: 39174524; preprint PMID:38352438 on medRxiv).


2. Etiology

Disease causal factor: Purely genetic/Mendelian. DEE49 is caused by biallelic (homozygous or compound heterozygous) pathogenic variants in DENND5A — there is no known environmental, infectious, or acquired etiology described in the literature.

Genetic risk factors

  • Inheritance pattern: Autosomal recessive. Disease requires two pathogenic alleles (homozygous or compound heterozygous).
  • Causal gene: DENND5A (HGNC:19344, chr 11p15.4), encoding a DENN-domain guanine nucleotide exchange factor (GEF).
  • Consanguinity as a risk factor: The founding families were consanguineous — "A consanguineous family from Saudi Arabia (family 1) presented with two affected sisters with epileptic encephalopathy" and "In family 2, the parents are first cousins" (PMID:27866705). Anazi et al. 2017 (PMID:27431290) likewise identified the D541G variant in "2 unrelated girls, each born of consanguineous parents." Consanguinity elevates the a priori risk of biallelic rare-variant disease and is consistent with the recessive model.
  • Variant spectrum (from the 2024 cohort, n=24 individuals/22 families): 30 unique variants — 25 coding-sequence variants, 2 copy-number variants (CNVs), and 3 intronic splice-site variants — distributed across the DENN domain (9 variants), RUN1 domain (2), PLAT domain (6), RUN2 domain (4), and inter-domain linker regions (4). 14 individuals were homozygous and 10 compound heterozygous.
  • Genotype-severity correlation (modifier effect of variant class): Biallelic frameshift/nonsense (complete loss-of-function) variants are associated with significantly worse neurological outcomes than missense variants (p = 0.0004 in the 2024 cohort) — i.e., variant type itself acts as a severity-modifying factor. Three individuals with specific variant combinations (p.K485E/p.R1159W; an exon 1–14 duplication; p.P955L/p.T136R) had markedly milder or non-DEE presentations (no seizures, normal MRI in some), illustrating that not every biallelic DENND5A genotype produces classic DEE49 and that variant-specific functional characterization is needed for interpretation.

Environmental risk factors

None reported. No toxin, occupational, infectious, or lifestyle exposure has been associated with DEE49 causation; this is consistent with its status as a monogenic recessive disorder.

Protective factors

None specifically documented. No protective genetic modifier or environmental protective factor has been reported in the literature to date.

Gene-environment interactions

Not applicable/not reported — no evidence of gene-environment interaction has been described for this monogenic disorder.


3. Phenotypes

Phenotype frequency data below are drawn from the 2024 Nature Communications natural-history cohort (Rodrigues et al., PMID:39174524; n = 24 individuals, 11 female/13 male, mean age 9.0 years, from 22 families), supplemented by the original OMIM clinical synopsis (#617281) and the 2016/2017 case reports.

Phenotype Frequency Notes / HPO term suggestion
Global developmental delay / intellectual disability 23/24 (96%) Near-universal; HP:0001263 (Global developmental delay), HP:0001249 (Intellectual disability)
Seizures 21/24 (87.5%) Mean onset 4.8 months (range includes neonatal onset per OMIM); focal-to-bilateral tonic-clonic most common. HP:0001250 (Seizure), HP:0032792 (Neonatal onset seizure), HP:0002007 (Frontal release signs — not applicable; use HP:0032917 Bilateral tonic-clonic seizure with focal onset if precise typing needed)
Microcephaly 16/24 (67%) Primary/congenital in many cases; OFC percentile highly variable. HP:0000252 (Microcephaly)
Ventriculomegaly 15/24 (63%) Often with normal head circumference (dissociates from microcephaly). HP:0002119 (Ventriculomegaly)
Hypertonia / spasticity 14/24 (58%) HP:0001276 (Hypertonia), HP:0001257 (Spasticity) — note OMIM synopsis lists hypotonia as well; tone findings can evolve from early hypotonia to later spasticity
Hypotonia Reported in OMIM synopsis (majority) HP:0001252 (Hypotonia)
Cerebral hypoplasia / reduced brain volume 13/24 (54%) Gray/white matter volume reduction on MRI. HP:0006872 (Cerebral hypoplasia)
Hyperreflexia 13/24 (54%) HP:0001347 (Hyperreflexia)
Nonverbal status / absent speech 15/24 (63%) HP:0001344 or HP:0002465 (Absent speech)
Corpus callosum dysgenesis/agenesis/hypoplasia Multiple cases (documented in both 2016 and 2024 series) HP:0002079 (Hypoplasia of the corpus callosum) / HP:0001274 (Agenesis of corpus callosum)
Brain (basal ganglia/periventricular/diencephalic) calcifications Multiple cases, including the original 2 sisters HP:0002514 (Basal ganglia calcification) / HP:0030955 (Cerebral calcification)
Coarse facial features All 4 original affected individuals, and additional cohort members HP:0000280 (Coarse facial features)
Specific facial features: open mouth, tented full upper lip, thick everted lower lip, short philtrum, large nostrils Documented in original family HP:0000212 (Tented upper lip vermilion), HP:0000232 (Everted lower lip vermilion), HP:0000322 (Short philtrum), HP:0000463 (Anteverted nares/large nostrils)
Frontal bossing Per OMIM clinical synopsis HP:0002007 — actually HP:0011220 (Frontal bossing)
Dandy-Walker malformation / posterior fossa cyst / hypoplastic vermis / diffuse hydrocephalus Subset of cases HP:0001305 (Dandy-Walker malformation), HP:0002365 (Poor head control) — use HP:0007360 (Aplasia/Hypoplasia of the cerebellar vermis)
Intellectual disability severity Severe (9), profound (3), moderate (2) of characterized subset Severity spectrum — HP:0010864 (Severe ID), HP:0002187 (Profound ID)

Age of onset: Neonatal-to-infantile. OMIM's clinical synopsis specifically notes "onset of seizures in the neonatal period" for the classic/severe presentation; the broader 2024 cohort reports mean seizure onset at 4.8 months (i.e., early infantile more often than strictly neonatal), reflecting phenotypic heterogeneity linked to variant type.

Severity and progression: Presentation ranges from a severe, classic DEE49 phenotype (neonatal/early-infantile refractory seizures, profound global developmental delay, absent speech, microcephaly, spasticity, coarse facies, and brain calcifications) to milder phenotypes without seizures or with normal neuroimaging in individuals carrying specific missense/hypomorphic variant combinations. The disease course is generally progressive/static-severe rather than degenerative — the core insult (impaired neurogenesis in utero) is developmental, but epilepsy itself can be refractory and lifelong, and developmental impairment is lifelong.

Quality of life impact: Not formally measured with standardized instruments (e.g., no EQ-5D/PROMIS data identified in the literature). Qualitatively, the cohort literature documents severe impact on independent function: the majority are nonverbal (63%), have global developmental delay (96%), and many have severe-to-profound intellectual disability, implying lifelong dependency for activities of daily living, consistent with other severe DEEs.


4. Genetic/Molecular Information

Causal gene

DENND5A (DENN Domain-Containing Protein 5A; also historically known as RAB6IP1 — Rab6-interacting protein 1), HGNC:19344, NCBI Gene ID 23258, chromosome 11p15.4. OMIM gene entry *617278; disease entry #617281 (DEE49).

Protein domain structure and function

DENND5A contains: - A DENN domain, "an evolutionarily ancient enzymatic module conferring guanine nucleotide exchange factor (GEF) activity to multiple proteins serving as GEFs for Rabs, which are key regulators of membrane trafficking" (PMID:27866705). - RUN1 domain: binds Rab6, which "regulates membrane trafficking and localizes to the trans-Golgi network (TGN)." - RUN2 (C-terminal RUN) domain: interacts with sorting nexin 1. - PLAT domain: site of several disease-associated variants in the expanded cohort (6/30 unique variants). - DENND5A functions as a GEF for Rab39 (Rab39A and/or Rab39B). - The protein contains an autoinhibitory intramolecular interaction between the DENN domain and the RUN1/PLAT domains, producing a "closed" conformation that masks binding sites for apical polarity-complex proteins; an "open" conformation is required for DENND5A to bind MUPP1 (Multi-PDZ Protein 1) and PALS1, core components of the Crumbs apical polarity complex that governs symmetric division of neural progenitor cells (Rodrigues et al. 2024, PMID:39174524). The patient variant p.Arg710His (R710H) destabilizes the closed state and increases MUPP1/PALS1 binding — a gain-of-interaction consequence of a disease variant, distinct from simple loss of GEF activity. - Subcellular localization: DENND5A localizes to the trans-Golgi network/recycling endosome compartment via Rab6, and a distinct pool localizes to γ-tubulin-positive centrosomes in neural progenitor cells, implicated in anchoring astral microtubules to the apical cortex to maintain mitotic spindle parallelism. - DENND5A is "detected predominantly in neuronal tissues with highest levels during development" and is expressed at highest levels in brain, with additional expression in peripheral nervous system and hematopoietic tissue (GeneCards/NCBI).

Pathogenic variants (specific examples reported in the literature)

Variant (cDNA/protein) Zygosity Source PMID
c.517_518delGA (p.Asp173Profs*8) Homozygous, family 1 (2 sisters) Suri et al. 2016 27866705
c.2547delG (p.Lys850Serfs*11) Homozygous, family 2 Suri et al. 2016 27866705
c.1622A>G (p.Asp541Gly, D541G) Homozygous, 2 unrelated girls Anazi et al. 2017 27431290
c.949+1G>A (splice) ClinVar RCV001808304, "Developmental and epileptic encephalopathy, 49"
c.2129G>A (p.Arg710His, R710H) Functional/structural characterization; destabilizes autoinhibited "closed" state Rodrigues et al. 2024 (39174524); ClinVar RCV000623720
30 unique variants total (25 coding SNVs/indels, 2 CNVs, 3 intronic splice-site variants) across DENN, RUN1, PLAT, RUN2, and linker regions 14 homozygous / 10 compound heterozygous Rodrigues et al. 2024 cohort (n=24) 39174524
  • Variant classification: Predominantly classified as pathogenic/likely pathogenic per ACMG/AMP criteria in ClinVar and by segregation with disease in consanguineous families; frameshift/nonsense variants are predicted loss-of-function.
  • Functional consequence: Predominantly loss of function (frameshift/nonsense truncations, splice-disrupting variants leading to reduced/absent protein), though at least one missense variant (R710H) produces a distinct gain-of-interaction mechanism (increased MUPP1/PALS1 binding via disrupted autoinhibition) rather than simple loss of GEF activity — illustrating allelic/mechanistic heterogeneity within the same gene.
  • Population allele frequency: Not specifically reported in the literature retrieved; as an ultra-rare recessive disease, pathogenic DENND5A alleles are expected to be rare/absent in gnomAD population databases (specific frequencies were not available in the sources reviewed here and should be confirmed directly in gnomAD before curation).
  • Somatic vs. germline: All reported variants are germline.
  • Modifier genes: None specifically identified; however, variant type (missense vs. frameshift/nonsense) functions as an intragenic severity modifier (p=0.0004 correlation with worse neurological outcome for truncating variants).
  • Epigenetic information / chromosomal abnormalities: No epigenetic (DNA methylation) mechanism reported. Two of the 30 reported variants in the expanded cohort are copy-number variants (including at least one exon 1–14 duplication), representing structural rather than point-mutation lesions.

Gene family context

DENND5A is one of two members of the DENND5 subfamily; its paralog DENND5B causes a distinct (largely non-overlapping) neurodevelopmental disorder via de novo variants, with DENND5B-mutant cells showing defective intracellular vesicle trafficking with impaired lipid uptake/distribution (PMID from PMC10940048/AJHG 2024). Both proteins interact with Rab6, Rab11, and Rab39, and are implicated in synaptic vesicle axonal trafficking and neurotransmitter release.


5. Environmental Information

No environmental factors, lifestyle factors, or infectious agents have been implicated in DEE49 causation or modification in the literature reviewed. This is expected for a fully penetrant autosomal recessive Mendelian disorder.


6. Mechanism / Pathophysiology

The pathophysiology of DENND5A-related DEE has been substantially clarified by the 2024 Nature Communications study (Rodrigues et al., PMID:39174524), which used patient-derived iPSCs, CRISPR knockout iPSC lines, a knock-in mouse model, and a zebrafish CRISPR F0 model to define a coherent causal chain from molecular lesion to clinical phenotype.

Causal chain (upstream → downstream)

  1. Molecular loss: Biallelic DENND5A variants → complete or near-complete loss of functional DENND5A protein (or, for select missense variants such as R710H, altered/gain-of-interaction function via disrupted domain autoinhibition).
  2. Apical polarity complex disruption: Loss of DENND5A → impaired/altered interaction with MUPP1 and PALS1, core Crumbs-complex apical polarity proteins → disrupted apical polarity complex in neural progenitor cells.
  3. Centrosome/spindle misorientation: Loss of the DENND5A centrosomal pool → impaired anchoring of astral microtubules to the apical cortex → misalignment of the mitotic spindle in dividing apical neural progenitors. Quantitatively, wild-type iPSC-derived neural rosette progenitors divide with a mean spindle angle of 57.1° (median 65.4°, symmetric/parallel divisions), whereas DENND5A-knockout progenitors divide with a mean spindle angle of 26.0° (median 20.1°) — "an overwhelming majority of KO cells divided with spindle angles <45°," indicating oblique/asymmetric division.
  4. Loss of symmetric self-renewing division / premature differentiation: Spindle misorientation biases inheritance of apical polarity determinants unequally between daughter cells, pushing progenitor daughters away from the apical proliferative niche and biasing them toward neuronal differentiation rather than continued self-renewal. Functionally, DENND5A-KO neural progenitor cells proliferate more slowly (614 vs. 1,008 cells per well at 48 hours in wild-type; p<0.0001) and differentiate prematurely into β-III-tubulin-positive neurons at markedly higher rates (47.29% vs. 10.67% in wild-type; p<0.0001) despite maintenance-medium conditions.
  5. Shortened neurogenesis / progenitor pool depletion: Premature exit from the proliferative/self-renewing progenitor compartment shortens the overall neurogenic period and depletes the progenitor pool prematurely.
  6. Structural brain consequences: Reduced/altered neurogenesis manifests as microcephaly, ventriculomegaly, cortical malformation, and corpus callosum dysgenesis — the core neuroimaging findings of the disorder.
  7. Functional/network consequences: Ectopically positioned and prematurely generated neurons plus resulting circuit hyperexcitability → seizures → secondary/compounding neurodevelopmental impairment (global developmental delay, intellectual disability).

Independent, complementary mechanism from the founding (2016) study — membrane trafficking / neurotrophin receptor signaling

The original discovery paper proposed a parallel/earlier mechanistic hypothesis centered on Rab-GEF-dependent membrane trafficking of neurotrophin receptors: - DENND5A's RUN1 domain binds Rab6 (trans-Golgi network trafficking regulator); its RUN2 domain binds sorting nexin 1; DENND5A additionally acts as a GEF for Rab39. - "Knockdown of DENND5A leads to striking alterations in neuronal development, and these changes appear to result from upregulation of neurotrophin receptors, leading to enhanced downstream signaling" (PMID:27866705). - In PC12 cells, DENND5A knockdown led to upregulation of TrkA and "significantly enhanced NGF-induced differentiation." In cultured cortical neurons, DENND5A knockdown led to upregulation of TrkB. - Proposed mechanism: loss of DENND5A impairs Rab-dependent lysosomal targeting/degradation of Trk (neurotrophin) receptors, causing their aberrant stabilization at the cell surface; increased Trk levels drive enhanced ERK/Erk activation, altering neurite outgrowth. In neuroblastoma cell contexts, unliganded TrkA overexpression/activation has separately been linked to apoptosis, leading the authors to hypothesize that "upregulation of Trk receptors due to DENND5A deficiency could lead to increased apoptosis in the developing brain" — though the authors explicitly note "the mechanisms whereby loss of DENND5A leads to enhanced amounts of neurotrophin receptor remain unknown."

These two mechanistic threads (apical-polarity/mitotic-spindle-driven premature neurogenesis, and Rab-GEF-dependent neurotrophin receptor trafficking/signaling dysregulation) are not mutually exclusive and both stem from DENND5A's core role as a Rab-GEF/membrane-trafficking regulator; the 2024 paper represents the more mechanistically resolved and cohort-validated model.

Cell types and biological processes implicated

  • Apical (radial glial) neural progenitor cells — primary affected cell type; Cell Ontology candidate: CL:0002608 (radial glial cell) or CL:0000060 (neural progenitor cell)
  • Cortical/pyramidal neurons — downstream, prematurely generated
  • PC12 cells / cortical neurons in vitro — model systems for neurotrophin signaling studies

Suggested GO terms

  • GO:0007095 — mitotic cell cycle G2/M transition / more precisely GO:0000280 (nuclear division) and GO:0051301 (cell division)
  • GO:0033045 — regulation of sister chromatid segregation (spindle-orientation adjacent)
  • GO:0051654 — establishment of mitotic spindle localization / GO:0000132 (establishment of mitotic spindle orientation)
  • GO:0005093 — Rab GDP-dissociation inhibitor binding / GO:0005085 (guanyl-nucleotide exchange factor activity)
  • GO:0032313 — regulation of Rab GTPase activity
  • GO:0045175 — basolateral protein secretion (apical-basal polarity adjacent) / GO:0045197 (establishment or maintenance of epithelial cell apical/basal polarity)
  • GO:0030154 — cell differentiation; GO:0022008 — neurogenesis
  • GO:0008285 — negative regulation of cell population proliferation

Suggested CHEBI/protein/complex references

  • Crumbs polarity complex components: CRB2, MUPP1/PATJ, PALS1
  • Rab GTPases: RAB6A, RAB39A, RAB39B
  • Neurotrophin receptors: NTRK1 (TrkA), NTRK2 (TrkB)

7. Anatomical Structures Affected

Organ level: - Primary organ: Central nervous system (brain), specifically cerebral cortex, ventricular system, corpus callosum, basal ganglia, and (in a subset) posterior fossa/cerebellum. - Secondary involvement: Facial skeleton/soft tissue (coarse facial features are a recognized dysmorphic feature, though not a distinct "organ" pathology per se — likely a downstream/coincidental developmental field effect rather than a primary independent lesion). - Body systems: Nervous system (primary); musculoskeletal system secondarily via hypotonia/spasticity and motor impairment.

Suggested UBERON terms: - UBERON:0000955 — brain - UBERON:0001851 — cortex (cerebral cortex) - UBERON:0002037 — cerebellum - UBERON:0002316 — white matter of corpus callosum / UBERON:0002336 — corpus callosum-adjacent structure - UBERON:0002020 — gray matter - UBERON:0002450 — basal ganglion - UBERON:0035927 — lateral ventricle (ventriculomegaly site)

Tissue and cell level: - Neuroepithelium / apical neural progenitor (radial glia) niche lining the ventricular zone — the primary site of the mitotic spindle-misorientation defect. - Cortical neurons (downstream, prematurely and ectopically generated).

Subcellular level: - Centrosome (γ-tubulin-positive) — DENND5A localization site relevant to spindle orientation. GO Cellular Component: GO:0005813 (centrosome). - Trans-Golgi network — Rab6-dependent trafficking compartment. GO:0005802 (trans-Golgi network). - Recycling endosome — Rab39-related trafficking. GO:0055037 (recycling endosome). - Mitotic spindle — GO:0072686 (mitotic spindle). - Apical plasma membrane / adherens junction — site of Crumbs-complex polarity signaling. GO:0016327 (apicolateral plasma membrane).

Localization: Findings are generally bilateral/diffuse (e.g., bilateral basal ganglia calcifications, generalized microcephaly, bilateral ventriculomegaly) rather than lateralized/asymmetric, consistent with a global developmental defect in neurogenesis rather than a focal lesion.


8. Temporal Development

Onset: Congenital/neonatal-to-early-infantile. The classic severe phenotype has neonatal-onset seizures (per OMIM clinical synopsis); the broader 2024 cohort documents a mean seizure onset of 4.8 months, reflecting a spectrum from neonatal to infantile onset depending on variant severity. The underlying neurodevelopmental insult (impaired progenitor symmetric division) is prenatal, occurring during cortical neurogenesis.

Onset pattern: Insidious-to-acute for seizures (which can present abruptly); the structural brain phenotype (microcephaly, ventriculomegaly, corpus callosum dysgenesis) is congenital and often detectable on prenatal or early postnatal imaging.

Progression: - The structural/developmental brain lesion itself is a fixed, non-degenerative, prenatally-established encephalopathy (progenitor pool is not being progressively lost postnatally by a distinct ongoing pathological process, as far as reported). - The clinical course is one of static-to-progressive global developmental impairment plus refractory, ongoing epilepsy — the DEE label specifically denotes that ongoing epileptic activity itself may contribute to progressive cognitive/developmental decline, a hallmark of the DEE nosological category generally. - Disease duration: chronic, lifelong (no reported spontaneous resolution).

Patterns: - No formal remission-pattern data identified. - No specific "critical period" intervention window has been established in the literature reviewed, although the underlying mechanism (a defect in prenatal apical progenitor symmetric division) implies that the therapeutic window for any mechanism-targeted intervention would need to act prenatally or in early neurogenesis to affect the structural brain phenotype — postnatal interventions would primarily target seizure control and developmental support rather than reversing the structural lesion.


9. Inheritance and Population

Epidemiology: DEE49 is an ultra-rare disorder. No formal population prevalence or incidence estimate was identified in the literature retrieved (consistent with fewer than ~30 published cases worldwide as of the 2024 cohort study). Given ultra-rarity and recessive inheritance concentrated in consanguineous families (Saudi Arabian, and other reported ancestries in the expanded cohort), it likely falls into an Orphanet prevalence class of "<1/1,000,000" or "unknown/not yet documented" pending a systematic prevalence study.

Inheritance pattern: Autosomal recessive (AR), confirmed by segregation analysis in multiple consanguineous families and by the pattern of homozygous/compound heterozygous genotypes across the full reported cohort (14 homozygous, 10 compound heterozygous of 24 individuals).

Penetrance: Appears to be high/complete for the core homozygous loss-of-function genotype, though phenotypic expressivity is broad (see below) and a subset of biallelic genotypes (particular missense combinations) produce mild-to-absent DEE phenotype, suggesting either incomplete penetrance or (more likely, per the authors) genuinely hypomorphic/less pathogenic alleles rather than true non-penetrance of fully pathogenic alleles.

Expressivity: Markedly variable — ranging from classic severe neonatal-onset DEE49 with microcephaly, refractory seizures, brain calcifications, and coarse facies, to milder presentations with global developmental delay alone, autism spectrum disorder without seizures, or normal neuroimaging, correlating substantially with variant class (truncating vs. missense) and specific residue/domain affected.

Genetic anticipation: Not reported/not applicable (no repeat-expansion mechanism involved).

Germline mosaicism: Not specifically reported in the literature reviewed.

Founder effects: Not formally established, though the concentration of reported cases in consanguineous Middle Eastern (Saudi Arabian) families in the founding reports raises the possibility of population-specific founder or recurrent alleles; this should be confirmed against gnomAD/regional population databases.

Consanguinity: A clearly documented risk factor — both founding families (Suri et al. 2016) and the Anazi et al. 2017 cases arose from consanguineous unions, consistent with autosomal recessive inheritance of a very rare allele.

Carrier frequency: Not established in the literature reviewed; expected to be very low/population-specific given the disorder's rarity.

Population demographics: - Affected populations: Cases have been reported predominantly from consanguineous families, initially Saudi Arabian; the expanded 2024 cohort (22 families) likely includes broader geographic/ethnic representation, though a systematic geographic breakdown was not retrieved in this research pass. - Sex ratio: The 2024 cohort comprised 11 female and 13 male individuals (~1.2:1 male:female) — roughly balanced, consistent with autosomal (non-X-linked) inheritance. - Age distribution: Cohort mean age 9.0 years at time of study (pediatric-to-young-adult range), consistent with a disorder identified and studied primarily in the pediatric population.


10. Diagnostics

Clinical/laboratory tests: No disease-specific biochemical biomarker has been identified; diagnosis relies on genetic testing plus clinical/neuroimaging correlation.

Neuroimaging (a key diagnostic pillar): - Brain MRI: ventriculomegaly, cerebral hypoplasia (reduced brain volume), corpus callosum dysgenesis/agenesis/hypoplasia, and in a subset, Dandy-Walker malformation, posterior fossa cyst, hypoplastic cerebellar vermis, or diffuse hydrocephalus. - Head CT: basal ganglia and periventricular/diencephalic calcifications (as in the original two affected sisters, who had "multiple small foci of calcification in the basal ganglia"). - The authors explicitly recommend: "Individuals with corpus callosum volume changes and/or microcephaly should be screened for DENND5A variants."

Electrophysiology: - EEG: Would be expected to show epileptiform activity consistent with the clinical seizure semiology (focal-to-bilateral tonic-clonic being most common), though specific EEG pattern data (e.g., burst-suppression, hypsarrhythmia) were not detailed in the sources retrieved here and should be confirmed against the primary cohort paper's supplementary phenotype tables.

Genetic testing (the primary diagnostic modality): - Whole-exome sequencing (WES) was the diagnostic method in essentially all reported cases (Suri et al. 2016 used WES in consanguineous families; Anazi et al. 2017 identified their variant via WES of 337 individuals with intellectual disability). - Gene panels: DENND5A is included on Orphanet's "Molecular diagnosis of Epileptic Encephalopathy" gene panel (EPI02v17.1) and commercial early-onset/syndromic epilepsy gene panels (e.g., Genomics England PanelApp "Early onset or syndromic epilepsy" panel and "Hydrocephalus" panel — reflecting the ventriculomegaly/hydrocephalus phenotype overlap). - Chromosomal microarray (CMA): relevant given that 2 of 30 reported variants in the expanded cohort were copy-number variants (deletions/duplications), so CMA/exome CNV calling should be part of a complete diagnostic workup, not single-gene sequencing alone. - Single-gene Sanger confirmation: used in the founding studies to confirm and segregate WES-identified variants within families. - Whole-genome sequencing (WGS) would be expected to have superior sensitivity for detecting intronic splice-site variants (3 of 30 reported variants were intronic).

Screening: No population-based or newborn screening program exists for this ultra-rare recessive disorder. Carrier screening/genetic counseling is relevant primarily in the context of known consanguinity or a family history of an affected individual, given the well-documented consanguinity association.

Differential diagnosis: Other genetic developmental and epileptic encephalopathies presenting with microcephaly, ventriculomegaly, and/or corpus callosum abnormalities (the broader DEE gene panel differential), and other syndromes with coarse facial features and brain calcification (e.g., Aicardi-Goutières syndrome and other interferonopathies presenting with basal ganglia calcification, though these have distinct immunological/inflammatory markers not described for DEE49).


11. Outcome/Prognosis

Survival/mortality: No formal survival statistics (5-year/10-year survival, mortality rate) were identified in the literature reviewed; DEE49 is not generally described as directly life-limiting in the sources reviewed, though refractory epilepsy in severe DEEs generally carries elevated mortality risk (e.g., SUDEP risk common to the DEE category broadly) — disease-specific mortality data for DEE49 specifically were not available in this research pass.

Morbidity/function: - Global developmental delay is nearly universal (96% in the 2024 cohort). - 63% of affected individuals are nonverbal. - Intellectual disability severity in a characterized subset: severe (9 cases), profound (3 cases), moderate (2 cases) — indicating substantial lifelong functional impairment for most affected individuals. - No standardized quality-of-life instrument data (EQ-5D, SF-36, PROMIS) were identified for this specific disorder.

Complications: Refractory seizures represent the dominant ongoing complication; hypertonia/spasticity (58%) and hyperreflexia (54%) suggest a significant proportion develop upper motor neuron signs contributing to motor disability.

Prognostic factors: The single strongest documented prognostic factor is variant class — biallelic frameshift/nonsense (complete loss-of-function) genotypes correlate with significantly worse neurological outcome scores than missense genotypes (p=0.0004), making genotype a genuinely predictive prognostic biomarker in this disease, unusual among ultra-rare DEEs for having this level of genotype-phenotype resolution in a cohort of this size.

Recovery potential: No disease-modifying therapy exists; the structural neurodevelopmental lesion (established prenatally via impaired progenitor symmetric division) is not expected to be reversible with current management, which remains supportive/symptomatic (see Treatment section).


12. Treatment

No disease-specific, mechanism-targeted therapy currently exists for DEE49. Management is symptomatic/supportive, following general principles for developmental and epileptic encephalopathies:

Pharmacotherapy (symptomatic seizure control): - Standard anti-seizure medications (ASMs) as used broadly across refractory pediatric DEEs (e.g., valproate, levetiracetam, and other agents used per individual seizure semiology); no DEE49-specific ASM efficacy data (e.g., a published responder series to a particular ASM) were identified in this literature pass. - NCIT suggestion: NCIT:C15986 (Pharmacotherapy) as the generic treatment_term for ASM use, with individual agents specified via therapeutic_agent (CHEBI) once specific regimens are documented from a primary source.

Dietary/non-pharmacological therapy: - The ketogenic diet is a generally effective option for drug-resistant epilepsy broadly (per general epilepsy literature reviewed: ~16% seizure-free, ~56% with >50% seizure reduction in general drug-resistant cohorts), and would be a reasonable consideration for refractory DEE49 seizures by extrapolation from general DEE/drug-resistant epilepsy management principles — but no DEE49-specific ketogenic diet outcome data were identified in the literature reviewed. - NCIT suggestion: NCIT:C15447 (Dietary Intervention).

Supportive/rehabilitative care: - Physical therapy, occupational therapy, and speech/communication therapy are indicated given the high prevalence of hypotonia/spasticity, motor impairment, and nonverbal status, per general standard-of-care principles for severe DEEs (not DEE49-specific published data). - NCIT suggestions: NCIT:C15302 (Physical Therapy), NCIT:C121351 (Occupational Therapy — per general NCIT catalog), NCIT:C159273 (Speech Therapy).

Genetic counseling: - Recommended for families given the autosomal recessive inheritance pattern and documented consanguinity association, to inform recurrence-risk counseling (25% recurrence risk for future pregnancies of carrier parents) and prenatal/preimplantation testing options once a familial pathogenic variant is identified. - NCIT suggestion: NCIT:C15240 (Genetic Counseling).

Experimental/targeted therapy: None identified in clinical trials (no NCT-registered interventional trial specific to DENND5A/DEE49 was found in this research pass). Given the mechanistic insight that DENND5A loss disrupts a Crumbs-complex/apical-polarity-dependent mitotic spindle orientation mechanism during a narrow prenatal neurogenic window, there is currently no plausible postnatal molecular correction strategy (e.g., no ASO, gene-replacement, or small-molecule approach has been reported), distinguishing this from other monogenic DEEs where postnatal genetic/RNA-based therapies are more mechanistically tractable (since the core lesion is developmental/structural rather than an ongoing biochemical deficiency).

Treatment outcomes / algorithms: No DEE49-specific treatment-response or treatment-algorithm data were identified; management follows general drug-resistant/DEE epilepsy treatment algorithms (sequential ASM trials, consideration of dietary therapy, and supportive multidisciplinary care).


13. Prevention

No primary, secondary, or tertiary prevention strategy specific to DEE49 exists beyond standard genetic counseling and reproductive options available for any autosomal recessive Mendelian disorder once a causative variant is identified in a family:

  • Genetic counseling for at-risk (particularly consanguineous) families, informing 25% recurrence risk per pregnancy for carrier couples.
  • Prenatal diagnosis / preimplantation genetic diagnosis (PGD) would be technically feasible once a familial pathogenic variant is molecularly confirmed, though no specific published program or uptake data for DEE49 were identified.
  • Carrier screening: not part of any standard population carrier-screening panel given the disorder's extreme rarity; relevant primarily in the context of known family history or specific consanguineous-community carrier programs (not documented specifically for DENND5A in the sources reviewed).
  • No immunization, public-health, or environmental-intervention prevention strategy applies, consistent with the disorder's purely genetic etiology.

14. Other Species / Natural Disease

Mouse: Dennd5a orthologue is annotated in Mouse Genome Informatics (MGI:1201681). A knock-in mouse model homozygous for the human-equivalent frameshift variant (c.517_518delGA / p.D173Pfs8) was generated and characterized in the 2024 study: - MRI (7 Tesla): significantly enlarged lateral ventricles (WT 4.8 mm³ vs. KI 6.6 mm³; p=0.034) — ventriculomegaly without overt microcephaly, recapitulating a key human phenotype (dissociation of ventriculomegaly from microcephaly seen in a subset of patients). - Reduced Dennd5a mRNA expression in brain tissue (p=0.046), consistent with nonsense-mediated decay of the frameshift transcript. - Increased seizure susceptibility*: shorter latency to seizure onset upon 4-aminopyridine (potassium channel blocker) challenge (WT latency 23.60 s vs. KI 11.67 s; p=0.007) — a pharmacoconvulsant-provoked seizure-susceptibility phenotype directly modeling the human epilepsy phenotype. - Histology of the adult subventricular zone: significantly increased proportion of NeuN-positive (mature) neurons (WT 39.6% vs. KI 58.8%; p=0.001), directly supporting the "premature neuronal differentiation at the expense of progenitor self-renewal" mechanism inferred from human iPSCs.

Zebrafish: F0 CRISPR knockout larvae (dennd5a orthologue) showed: - Reduced head size - Increased hindbrain ventricle size (p=0.028) — a ventriculomegaly analog - Altered locomotor activity during light/dark cycle assays - Reduced visual and acoustic startle responses - Reduced eye size

This cross-species conservation (mouse ventriculomegaly + seizure susceptibility; zebrafish microcephaly-like/ventricular phenotypes) across two independent vertebrate model systems substantially strengthens causality and supports the fundamental, evolutionarily conserved developmental importance of DENND5A in neurogenesis.

Naturally occurring disease in companion/veterinary species: No naturally occurring DENND5A-associated disease in companion animals or livestock was identified (no OMIA entry found in this search); the described animal models are exclusively laboratory-induced (CRISPR/knock-in), not naturally occurring veterinary disease.

Comparative biology: The core mechanism (Crumbs-complex-dependent apical progenitor symmetric division controlling neurogenesis output) is a deeply conserved developmental biology pathway across vertebrates, explaining why both mouse and zebrafish models recapitulate aspects of the human phenotype despite species differences in brain complexity.


15. Model Organisms

Model type System Genetic modification Key phenotypes recapitulated Fidelity/limitations
Human iPSC (cellular model) Patient-derived and CRISPR-KO iPSC-derived neural progenitor cells (neural rosette assay) DENND5A knockout / patient-derived lines Mitotic spindle misorientation (57.1°→26.0° mean angle), reduced proliferation, premature β-III-tubulin+ neuronal differentiation High fidelity for the core cell-autonomous progenitor mechanism; does not model whole-organism seizure phenotype
Mouse (in vivo genetic model) Knock-in mouse, homozygous p.D173Pfs*8 (human-equivalent frameshift) CRISPR knock-in Ventriculomegaly (MRI), reduced brain Dennd5a mRNA, increased seizure susceptibility (4-AP challenge), increased mature (NeuN+) neuron proportion in SVZ Recapitulates ventriculomegaly and seizure susceptibility; did not show overt microcephaly in all mice (partial fidelity to the human microcephaly phenotype — a HUMAN_MODEL_MISMATCH-type caveat)
Zebrafish (in vivo genetic model) F0 CRISPR knockout larvae CRISPR/Cas9 F0 knockout Reduced head size, increased hindbrain ventricle size, altered locomotor activity, reduced visual/acoustic startle, reduced eye size Useful for rapid high-throughput phenotype screening; F0 mosaic knockout (not stable germline line) is a limitation on genotype-phenotype precision
Rat pheochromocytoma cell line (PC12) In vitro neurotrophin-signaling model DENND5A knockdown (siRNA/shRNA) Upregulated TrkA, enhanced NGF-induced differentiation Cancer cell line model of neurotrophin receptor trafficking, not neurogenesis per se; complements but is mechanistically distinct from the 2024 progenitor-division model
Primary cultured cortical neurons In vitro DENND5A knockdown Upregulated TrkB Post-mitotic neuron model; informative for the neurotrophin-signaling arm of the mechanism, not the progenitor-division arm

Resources: MGI:1201681 (mouse Dennd5a gene page); no dedicated public repository line accession numbers (e.g., IMSR/EMMA/MMRRC ID) were identified in this research pass for the specific knock-in line — this should be confirmed directly from the Nature Communications 2024 paper's Methods/Data Availability section if a specific strain repository accession is needed for curation.


Summary of Key Ontology Term Suggestions for KB Curation

  • Disease: OMIM:617281; HGNC gene: hgnc:19344 (DENND5A)
  • Inheritance: HP:0000007 (Autosomal recessive inheritance)
  • Key phenotypes: HP:0001250 (Seizure), HP:0000252 (Microcephaly), HP:0002119 (Ventriculomegaly), HP:0002079 (Hypoplasia of the corpus callosum), HP:0030955 (Cerebral calcification), HP:0000280 (Coarse facial features), HP:0001263 (Global developmental delay), HP:0001276 (Hypertonia), HP:0001252 (Hypotonia), HP:0001347 (Hyperreflexia), HP:0006872 (Cerebral hypoplasia)
  • Cell types: CL:0002608 (radial glial cell) / neural progenitor cell equivalent
  • Biological processes (GO): GO:0000132-type spindle-orientation terms, GO:0022008 (neurogenesis), GO:0005085 (guanyl-nucleotide exchange factor activity), GO:0045197 (epithelial apical/basal polarity establishment/maintenance)
  • Anatomy (UBERON): UBERON:0000955 (brain), UBERON:0001851 (cerebral cortex), UBERON:0002450 (basal ganglion), UBERON:0035927 (lateral ventricle)
  • Treatments (NCIT): NCIT:C15986 (Pharmacotherapy, for ASMs), NCIT:C15447 (Dietary Intervention, ketogenic diet), NCIT:C15240 (Genetic Counseling), NCIT:C15302 (Physical Therapy)

Sources

Reference Validation

Checked with linkml-reference-validator 0.2.1.

Outcome Count
References checked 7
Resolved 7
Unresolved (possible confabulation) 0
Unverifiable 0
Quoted claims checked 1
Quoted claims found in source 1
Quoted claims not found in source 0
References weighed for topical relevance 7
On topic 7
Off topic 0

All extracted references resolved successfully.